论文信息 - Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs

Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs

[1] 坂平英樹. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis , 2000 .

[2] Kyu-Jin Park,et al. Cell cycle arrest mediated by hepatitis delta antigen , 1999, FEBS letters.

[3] M. Welham,et al. Dissociation of Apoptosis from Proliferation, Protein Kinase B Activation, and BAD Phosphorylation in Interleukin-3-mediated Phosphoinositide 3-Kinase Signaling* , 1999, The Journal of Biological Chemistry.

[4] C. Mcwherter,et al. Circular permutation of granulocyte colony-stimulating factor. , 1999, Biochemistry.

[5] C. Mcwherter,et al. Circular permutation of the granulocyte colony-stimulating factor receptor agonist domain of myelopoietin. , 1999, Biochemistry.

[6] P. Hall,et al. DT388-GM-CSF, a novel fusion toxin consisting of a truncated diphtheria toxin fused to human granulocyte–macrophage colony-stimulating factor, prolongs host survival in a SCID mouse model of acute myeloid leukemia , 1999, Leukemia.

[7] W. Fleming,et al. Administration of daniplestim and granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in nonhuman primates. , 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8] C. Pui,et al. The role of TEL fusion genes in pediatric leukemias , 1999, Leukemia.

[9] C. Niemeyer,et al. RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML) , 1999, Leukemia.

[10] M. Mumby,et al. Reversible Phosphorylation of Bcl2 following Interleukin 3 or Bryostatin 1 Is Mediated by Direct Interaction with Protein Phosphatase 2A* , 1998, The Journal of Biological Chemistry.

[11] J. McCubrey,et al. Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells , 1998, Leukemia.

[12] A. Hagenbeek,et al. GM-CSF receptor targeted treatment of primary AML in SCID mice using Diphtheria toxin fused to huGM-CSF , 1998, Leukemia.

[13] H. Quentmeier,et al. Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e , 1998, Leukemia.

[14] J. Yasuda,et al. A mammalian scaffold complex that selectively mediates MAP kinase activation. , 1998, Science.

[15] H. Schaeffer,et al. MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. , 1998, Science.

[16] K Yuge,et al. A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons. , 1998, Blood.

[17] P. Graves,et al. 14-3-3 Proteins Are Required for Maintenance of Raf-1 Phosphorylation and Kinase Activity , 1998, Molecular and Cellular Biology.

[18] S. Cory,et al. The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.

[19] G. Evan,et al. A matter of life and cell death. , 1998, Science.

[20] Y. Lazebnik,et al. Caspases: enemies within. , 1998, Science.

[21] F. Durrieu,et al. Apparent caspase independence of programmed cell death in Dictyostelium , 1998, Current Biology.

[22] Kohji Sato,et al. Interleukin 3 Prevents Delayed Neuronal Death in the Hippocampal CA1 Field , 1998, The Journal of experimental medicine.

[23] C. Thompson,et al. Bcl-2-family proteins: the role of the BH3 domain in apoptosis. , 1998, Trends in cell biology.

[24] D. Link,et al. Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia. , 1998, The Journal of clinical investigation.

[25] J. Gasson,et al. Characterization of the role of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit in the activation of JAK2 and STAT5. , 1998, Blood.

[26] S. Korsmeyer,et al. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis , 1998, The EMBO journal.

[27] G. Núñez,et al. Regulation of Bcl-xl Channel Activity by Calcium* , 1998, The Journal of Biological Chemistry.

[28] A. Chinnaiyan,et al. The Death Inhibitory Molecules CED-9 and CED-4L Use a Common Mechanism to Inhibit the CED-3 Death Protease* , 1998, The Journal of Biological Chemistry.

[29] J Bondeson,et al. Efficient adenoviral infection with IkappaB alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappaB dependent. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30] L. E. McDonald,et al. Distinct Methylation of the Interferon γ (IFN-γ) and Interleukin 3 (IL-3) Genes in Newly Activated Primary CD8+ T Lymphocytes: Regional IFN-γ Promoter Demethylation and mRNA Expression Are Heritable in CD44highCD8+ T Cells , 1998, The Journal of experimental medicine.

[31] M. Scheid,et al. Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: involvement of MEK upstream of Bad phosphorylation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32] A. Moustakas,et al. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33] S. Korsmeyer,et al. Involvement of Microtubules in the Regulation of Bcl2 Phosphorylation and Apoptosis through Cyclic AMP-Dependent Protein Kinase , 1998, Molecular and Cellular Biology.

[34] V. Cryns,et al. Proteases to die for. , 1998, Genes & development.

[35] H. Drexler. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia–lymphoma cells , 1998, Leukemia.

[36] G. Krystal,et al. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. , 1998, Genes & development.

[37] Michael P. Brown,et al. Stat5a and Stat5b Proteins Have Essential and Nonessential, or Redundant, Roles in Cytokine Responses , 1998, Cell.

[38] D. Templeton,et al. Induction of Cyclooxygenase-2 by the Activated MEKK1 → SEK1/MKK4 → p38 Mitogen-activated Protein Kinase Pathway* , 1998, The Journal of Biological Chemistry.

[39] John Calvin Reed,et al. Modulation of Bcl-2 protein levels by an intracellular anti-Bcl-2 single-chain antibody increases drug-induced cytotoxicity in the breast cancer cell line MCF-7. , 1998, Cancer research.

[40] H. Horvitz,et al. The C. elegans Protein EGL-1 Is Required for Programmed Cell Death and Interacts with the Bcl-2–like Protein CED-9 , 1998, Cell.

[41] N. Hamasaki,et al. Constitutive activation of Jak‐2 and Tyk‐2 in a v‐Src‐transformed human gallbladder adenocarcinoma cell line , 1998, Journal of cellular physiology.

[42] D. Vaux,et al. Conservation of baculovirus inhibitor of apoptosis repeat proteins (BIRPs) in viruses, nematodes, vertebrates and yeasts. , 1998, Trends in biochemical sciences.

[43] I. Campbell. Structural and Functional Impact of the Transgenic Expression of Cytokines in the CNS a , 1998, Annals of the New York Academy of Sciences.

[44] A. Farese,et al. The combined administration of daniplestim and mpl ligand augments the hematopoietic reconstitution observed with single cytokine administration in a nonhuman primate model of myelosuppression , 1998, Stem cells.

[45] T. Tabira,et al. Interleukin‐3 and Interleukin‐3 Receptors in the Brain a , 1998, Annals of the New York Academy of Sciences.

[46] Z. Liu,et al. IL-3 withdrawal activates a CrmA-insensitive poly(ADP-ribose) polymerase cleavage enzyme in factor-dependent myeloid progenitor cells , 1998, Leukemia.

[47] A. Hagenbeek,et al. In vivo targeting of leukemic cells using diphtheria toxin fused to murine GM-CSF , 1998, Leukemia.

[48] M. Moskowitz,et al. Defects in regulation of apoptosis in caspase-2-deficient mice. , 1998, Genes & development.

[49] R. Schreiber,et al. Disruption of the Jak1 Gene Demonstrates Obligatory and Nonredundant Roles of the Jaks in Cytokine-Induced Biologic Responses , 1998, Cell.

[50] J. Marine,et al. Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors , 1998, Cell.

[51] G. Kroemer,et al. Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins , 1998, Oncogene.

[52] Xiao-Fan Wang,et al. Inhibition of the 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Pathway Induces p53-independent Transcriptional Regulation of p21 WAF1/CIP1 in Human Prostate Carcinoma Cells* , 1998, The Journal of Biological Chemistry.

[53] Samir A. Shah,et al. T Cell–mediated Pathology in Two Models of Experimental Colitis Depends Predominantly on the Interleukin 12/Signal Transducer and Activator of Transcription (Stat)-4 Pathway, but Is Not Conditional on Interferon γ Expression by T Cells , 1998, The Journal of experimental medicine.

[54] P. Herrlich,et al. Autocrine growth and anchorage independence: two complementing Jun-controlled genetic programs of cellular transformation. , 1998, Genes & development.

[55] Yuanming Hu,et al. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[56] C. Marshall,et al. Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. , 1998, Science.

[57] D. Heimbrook,et al. Therapeutic intervention and signaling. , 1998, Current opinion in cell biology.

[58] J. Downward. Mechanisms and consequences of activation of protein kinase B/Akt. , 1998, Current opinion in cell biology.

[59] K. Tsuchiya,et al. Cell cycle arrest and antitumor activity of pironetin and its derivatives. , 1998, Cancer letters.

[60] M. Scheid,et al. Downstream signalling events regulated by phosphatidylinositol 3-kinase activity. , 1998, Cellular signalling.

[61] M. Cluck,et al. Mechanisms controlling cellular suicide: role of Bcl-2 and caspases , 1998, Cellular and Molecular Life Sciences CMLS.

[62] M. Lebwohl,et al. Inhibition of ultraviolet B (UVB)-induced c-fos and c-jun expression in vivo by a tyrosine kinase inhibitor genistein. , 1998, Carcinogenesis.

[63] R. Cozens,et al. A potent protein‐tyrosine kinase inhibitor which selectively blocks proliferation of epidermal growth factor receptor‐expressing tumor cells in vitro and in vivo , 1998 .

[64] C. Widmann,et al. Caspase-dependent Cleavage of Signaling Proteins during Apoptosis , 1998, The Journal of Biological Chemistry.

[65] V. Dixit,et al. Caspase-9, Bcl-XL, and Apaf-1 Form a Ternary Complex* , 1998, The Journal of Biological Chemistry.

[66] C. Borner,et al. Alphaviruses induce apoptosis in Bcl‐2‐overexpressing cells: evidence for a caspase‐mediated, proteolytic inactivation of Bcl‐2 , 1998, The EMBO journal.

[67] A. Ullrich,et al. Activation of phosphatidylinositol 3-kinase is necessary for differentiation of FDC-P1 cells following stimulation of type III receptor tyrosine kinases. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[68] R. Perlmutter,et al. Requirement for Jak3 in mature T cells: its role in regulation of T cell homeostasis. , 1998, Journal of immunology.

[69] L. Robb,et al. The biological consequences of excess GM-CSF levels in transgenic mice also lacking high-affinity receptors for GM-CSF , 1998, Leukemia.

[70] Junying Yuan,et al. Murine Caspase-11, an ICE-Interacting Protease, Is Essential for the Activation of ICE , 1998, Cell.

[71] R. DePinho,et al. Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[72] B. Mignotte,et al. Mitochondria and apoptosis. , 1998, European journal of biochemistry.

[73] S. Cory,et al. The conserved N‐terminal BH4 domain of Bcl‐2 homologues is essential for inhibition of apoptosis and interaction with CED‐4 , 1998, The EMBO journal.

[74] Z. Szallasi,et al. Overexpression of Protein Kinase C Isoform but not δ in Human Interleukin-3–Dependent Cells Suppresses Apoptosis and Induces bcl-2 Expression , 1998 .

[75] J Downward,et al. Ras signalling and apoptosis. , 1998, Current opinion in genetics & development.

[76] M. Mihm,et al. Involvement of interleukin-3 in delayed-type hypersensitivity. , 1998, Blood.

[77] Kenneth G. C. Smith,et al. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes , 1998, The EMBO journal.

[78] M. Andjelkovic,et al. Phosphorylation and activation of p70s6k by PDK1. , 1998, Science.

[79] F. McCormick,et al. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. , 1998, Science.

[80] C. Borner,et al. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c , 1998, Nature.

[81] D G Kirsch,et al. Modulation of cell death by Bcl-XL through caspase interaction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[82] A. Strasser,et al. Bim: a novel member of the Bcl‐2 family that promotes apoptosis , 1998, The EMBO journal.

[83] S. Nagata,et al. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD , 1998, Nature.

[84] C. Thompson,et al. Human IAP-Like Protein Regulates Programmed Cell Death Downstream of Bcl-xL and Cytochrome c , 1998, Molecular and Cellular Biology.

[85] J. Vilček,et al. Activation of p38 Mitogen-Activated Protein Kinase by Sodium Salicylate Leads to Inhibition of Tumor Necrosis Factor-Induced IκBα Phosphorylation and Degradation , 1998, Molecular and Cellular Biology.

[86] F. Durrieu,et al. Olie, R. A. et al. Apparent caspase independence of programmed cell death in Dictyostelium. Curr. Biol. 8, 955-958 , 1998 .

[87] I. Pastan,et al. Clinical trials with Pseudomonas exotoxin immunotoxins. , 1998, Current topics in microbiology and immunology.

[88] Z. Szallasi,et al. Overexpression of protein kinase C isoform epsilon but not delta in human interleukin-3-dependent cells suppresses apoptosis and induces bcl-2 expression. , 1998, Blood.

[89] H. Nakano,et al. Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[90] J. Vilček,et al. Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IkappaB alpha phosphorylation and degradation. , 1998, Molecular and cellular biology.

[91] A. Yoshimura. The CIS/JAB family: novel negative regulators of JAK signaling pathways , 1998, Leukemia.

[92] A. Khwaja,et al. A truncated isoform of the human beta chain common to the receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3), and IL-5 with increased mRNA expression in some patients with acute leukemia. , 1998, Blood.

[93] M. Yaffe,et al. The Structural Basis for 14-3-3:Phosphopeptide Binding Specificity , 1997, Cell.

[94] J L Cleveland,et al. Mammalian cells express two differently localized Bag-1 isoforms generated by alternative translation initiation. , 1997, The Biochemical journal.

[95] E. Cheng,et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. , 1997, Science.

[96] W. Kolch,et al. Protein kinase C-ε associates with the Raf-1 kinase and induces the production of growth factors that stimulate Raf-1 activity , 1997, Oncogene.

[97] A. Roulston,et al. Activation of hPAK65 by caspase cleavage induces some of the morphological and biochemical changes of apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[98] T. Billiar,et al. Nitric Oxide Inhibits Apoptosis by Preventing Increases in Caspase-3-like Activity via Two Distinct Mechanisms* , 1997, The Journal of Biological Chemistry.

[99] C. Smith,et al. The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. , 1997, Immunity.

[100] G. Thomas,et al. TOR signalling and control of cell growth. , 1997, Current opinion in cell biology.

[101] K. Stenmark,et al. Selected isozymes of PKC contribute to augmented growth of fetal and neonatal bovine PA adventitial fibroblasts. , 1997, American journal of physiology. Lung cellular and molecular physiology.

[102] A. Gurney,et al. A novel receptor for Apo2L/TRAIL contains a truncated death domain , 1997, Current Biology.

[103] M. Lisanti,et al. Interaction of a Receptor Tyrosine Kinase, EGF-R, with Caveolins , 1997, The Journal of Biological Chemistry.

[104] D. Haber. Splicing into Senescence: The Curious Case of p16 and p19ARF , 1997, Cell.

[105] T. Billiar,et al. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. , 1997, Biochemical and biophysical research communications.

[106] L. Berg,et al. T cells from Jak3-deficient mice have intact TCR signaling, but increased apoptosis. , 1997, Journal of immunology.

[107] N. Tonks,et al. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. , 1997, Science.

[108] S. Howell,et al. 14-3-3 Is Phosphorylated by Casein Kinase I on Residue 233 , 1997, The Journal of Biological Chemistry.

[109] M. Welham,et al. Interleukin-3 Induces Association of the Protein-tyrosine Phosphatase SHP2 and Phosphatidylinositol 3-Kinase with a 100-kDa Tyrosine-phosphorylated Protein in Hemopoietic Cells* , 1997, The Journal of Biological Chemistry.

[110] R Berger,et al. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. , 1997, Science.

[111] S. Srinivasula,et al. Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[112] W. Roush. On the Biotech Pharm, a Race to Harvest New Cancer Cures , 1997, Science.

[113] S. Lipton,et al. Suppression of neuronal apoptosis by S-nitrosylation of caspases , 1997, Neuroscience Letters.

[114] M. Barinaga. From Bench Top to Bedside , 1997, Science.

[115] J. Lacal,et al. Choline kinase inhibitors as a novel approach for antiproliferative drug design , 1997, Oncogene.

[116] Y. Tohyama,et al. Interleukin-3 activates Syk in a human myeloblastic leukemia cell line, AML193. , 1997, European journal of biochemistry.

[117] A. Hsueh,et al. Interference of BAD (Bcl-xL/Bcl-2-associated death promoter)-induced apoptosis in mammalian cells by 14-3-3 isoforms and P11. , 1997, Molecular endocrinology.

[118] A. Hagenbeek,et al. Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor eliminates acute myeloid leukemia cells with the potential to initiate leukemia in immunodeficient mice, but spares normal hemopoietic stem cells. , 1997, Blood.

[119] L. Peso,et al. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. , 1997, Science.

[120] R. Woscholski,et al. Tyrosine Phosphorylation and Relocation of SHIP Are Integrin-mediated in Thrombin-stimulated Human Blood Platelets* , 1997, The Journal of Biological Chemistry.

[121] H. Sakamoto,et al. Cloning and characterization of novel CIS family genes. , 1997, Biochemical and biophysical research communications.

[122] John Calvin Reed,et al. IFN-gamma upregulates anti-apoptotic gene expression and inhibits apoptosis in IL-3-dependent hematopoietic cells. , 1997, Biochemical and biophysical research communications.

[123] M. Kansara,et al. Acute regulation of glucose transport in a monocyte-macrophage cell line: Glut-3 affinity for glucose is enhanced during the respiratory burst. , 1997, The Biochemical journal.

[124] B. Trask,et al. MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[125] G Waksman,et al. Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[126] D. Baltimore,et al. Interleukin 3-dependent survival by the Akt protein kinase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[127] J. Massagué,et al. Differential Interaction of the Cyclin-dependent Kinase (Cdk) Inhibitor p27Kip1 with Cyclin A-Cdk2 and Cyclin D2-Cdk4* , 1997, The Journal of Biological Chemistry.

[128] S. Srinivasula,et al. Identification and Molecular Cloning of Two Novel Receptors for the Cytotoxic Ligand TRAIL* , 1997, The Journal of Biological Chemistry.

[129] Jay X. Tang,et al. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. , 1997, Science.

[130] H. Koide,et al. An activated mutant of R-Ras inhibits cell death caused by cytokine deprivation in BaF3 cells in the presence of IGF-I , 1997, Oncogene.

[131] Z. Liu,et al. Inhibition of caspase proteases by CrmA enhances the resistance of human leukemic cells to multiple chemotherapeutic agents , 1997, Leukemia.

[132] J. McCubrey,et al. Differential effects of retroviral long terminal repeats on interleukin-3 gene expression and autocrine transformation , 1997, Leukemia.

[133] S. Chen,et al. CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[134] B. Brüne,et al. Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide. , 1997, Biochemical and biophysical research communications.

[135] T. Tsuruo,et al. Requirement of the Caspase-3/CPP32 Protease Cascade for Apoptotic Death following Cytokine Deprivation in Hematopoietic Cells* , 1997, The Journal of Biological Chemistry.

[136] C. Mcwherter,et al. The Receptor Binding Site of Human Interleukin-3 Defined by Mutagenesis and Molecular Modeling* , 1997, The Journal of Biological Chemistry.

[137] Elizabeth J. Goldsmith,et al. Activation Mechanism of the MAP Kinase ERK2 by Dual Phosphorylation , 1997, Cell.

[138] E. Rowold,et al. Phage presentation and affinity selection of a deletion mutant of human lnterleukin-3 , 1997, Applied biochemistry and biotechnology.

[139] H. Osada. [Development of new antitumor reagents which block the cell cycle progression]. , 1997, Gan to kagaku ryoho. Cancer & chemotherapy.

[140] G. Feldman,et al. STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. , 1997, Blood.

[141] C. Olsson,et al. Development of a hammerhead ribozyme against bcl‐2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone‐refractory human prostate cancer , 1997, The Prostate.

[142] J A McCubrey,et al. Autocrine transformation of human hematopoietic cells after transfection with an activated granulocyte/macrophage colony stimulating factor gene. , 1997, Cytokines, cellular & molecular therapy.

[143] C. Olsson,et al. Development of a hammerhead ribozyme against BCL-2. II. Ribozyme treatment sensitizes hormone-resistant prostate cancer cells to apoptotic agents. , 1997, Anticancer research.

[144] M. Taniwaki,et al. Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia , 1997, Leukemia.

[145] A Sewing,et al. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1 , 1997, Molecular and cellular biology.

[146] M. McMahon,et al. Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1 , 1997, Oncogene.

[147] C. Der,et al. 14-3-3 ζ Negatively Regulates Raf-1 Activity by Interactions with the Raf-1 Cysteine-rich Domain* , 1997, The Journal of Biological Chemistry.

[148] H. Xiao,et al. Sodium butyrate induces NIH3T3 cells to senescence-like state and enhances promoter activity of p21WAF/CIP1 in p53-independent manner. , 1997, Biochemical and biophysical research communications.

[149] D. Kufe,et al. Caspase-3-mediated Cleavage of Protein Kinase C θ in Induction of Apoptosis* , 1997, The Journal of Biological Chemistry.

[150] R. Gentz,et al. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. , 1997, Science.

[151] W I Wood,et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. , 1997, Science.

[152] C. Der,et al. Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras? , 1997, Biochimica et biophysica acta.

[153] Y. Goltsev,et al. CASH, a Novel Caspase Homologue with Death Effector Domains* , 1997, The Journal of Biological Chemistry.

[154] Xiaodong Wang,et al. Apaf-1, a Human Protein Homologous to C. elegans CED-4, Participates in Cytochrome c–Dependent Activation of Caspase-3 , 1997, Cell.

[155] S. Yokoyama,et al. Raf/MAPK and rapamycin-sensitive pathways mediate the anti-apoptotic function of p21Ras in IL-3-dependent hematopoietic cells , 1997, Oncogene.

[156] S. Meloche,et al. Essential role of calcium in the regulation of MAP kinase phosphatase-1 expression , 1997, Oncogene.

[157] N. Thornberry,et al. Caspases: killer proteases. , 1997, Trends in biochemical sciences.

[158] A. King,et al. Phosphorylation of Raf-1 serine 338-serine 339 is an essential regulatory event for Ras-dependent activation and biological signaling , 1997, Molecular and cellular biology.

[159] C. Mcwherter,et al. Multiple conformations of a human interleukin‐3 variant , 1997, Protein science : a publication of the Protein Society.

[160] D. Altieri,et al. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma , 1997, Nature Medicine.

[161] G. Kroemer. The proto-oncogene Bcl-2 and its role in regulating apoptosis , 1997, Nature Medicine.

[162] M. Rosner,et al. Src tyrosine kinase mediates stimulation of Raf-1 and mitogen-activated protein kinase by the tumor promoter thapsigargin. , 1997, Cancer research.

[163] S. Bohm,et al. Characterization of a nuclear factor that binds juxtaposed with ATF3/Jun on a composite response element specifically mediating induced transcription in response to an epidermal growth factor/Ras/Raf signaling pathway. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[164] C. Demaria,et al. Identification of AUF1 (heterogeneous nuclear ribonucleoprotein D) as a component of the alpha-globin mRNA stability complex , 1997, Molecular and cellular biology.

[165] G. Salvesen,et al. The Regulation of Anoikis: MEKK-1 Activation Requires Cleavage by Caspases , 1997, Cell.

[166] F Gambale,et al. Inhibition of Bax channel-forming activity by Bcl-2. , 1997, Science.

[167] J. Selkirk,et al. p53-dependent p21 induction following gamma-irradiation without concomitant p53 induction in a human peripheral neuroepithelioma cell line. , 1997, Cancer research.

[168] A. Kraft,et al. The Cytoplasmic Domain of Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF) Receptor α Subunit Is Essential for Both GM-CSF-mediated Growth and Differentiation* , 1997, The Journal of Biological Chemistry.

[169] L. McKendrick,et al. Involvement of Stress-activated Protein Kinase and p38/RK Mitogen-activated Protein Kinase Signaling Pathways in the Enhanced Phosphorylation of Initiation Factor 4E in NIH 3T3 Cells* , 1997, The Journal of Biological Chemistry.

[170] Margot Thome,et al. Inhibition of death receptor signals by cellular FLIP , 1997, Nature.

[171] A Aitken,et al. Structure and Sites of Phosphorylation of 14-3-3 Protein: Role in Coordinating Signal Transduction Pathways , 1997, Journal of protein chemistry.

[172] G. Cooper,et al. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1 , 1997, Molecular and cellular biology.

[173] G. Panayotou,et al. Phosphoinositide 3-kinases: a conserved family of signal transducers. , 1997, Trends in biochemical sciences.

[174] Guy S. Salvesen,et al. X-linked IAP is a direct inhibitor of cell-death proteases , 1997, Nature.

[175] I. Touw,et al. Rarity of dominant-negative mutations of the G-CSF receptor in patients with blast crisis of chronic myeloid leukemia or de novo acute leukemia , 1997, Leukemia.

[176] U. Rapp,et al. Endothelial apoptosis in Braf-deficient mice , 1997, Nature Genetics.

[177] C. Pritchard,et al. Raf revealed in life-or-death decisions , 1997, Nature Genetics.

[178] S. Seshagiri,et al. Caenorhabditis elegans CED-4 stimulates CED-3 processing and CED-3-induced , 1997, Current Biology.

[179] Takaho A. Endo,et al. A new protein containing an SH2 domain that inhibits JAK kinases , 1997, Nature.

[180] Warren S. Alexander,et al. A family of cytokine-inducible inhibitors of signalling , 1997, Nature.

[181] R. Weichselbaum,et al. Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[182] T. Mustelin,et al. Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[183] T. Taniguchi,et al. The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[184] G. Thomas,et al. The modular phosphorylation and activation of p70s6k , 1997, FEBS letters.

[185] R. Nicholson,et al. New EGF‐R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC‐3 and DU‐145 , 1997, International journal of cancer.

[186] G M Bokoch,et al. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. , 1997, Science.

[187] A. Haman,et al. Crucial Role of the Residue R280 at the F′–G′ Loop of the Human Granulocyte/Macrophage Colony-stimulating Factor Receptor α Chain for Ligand Recognition , 1997, The Journal of experimental medicine.

[188] James M. Roberts,et al. Cyclin E-CDK2 is a regulator of p27Kip1. , 1997, Genes & development.

[189] H. Hirsch,et al. Rapamycin destabilizes interleukin-3 mRNA in autocrine tumor cells by a mechanism requiring an intact 3' untranslated region , 1997, Molecular and cellular biology.

[190] S. Bhattacharya,et al. JAK2 is required for induction of the murine DUB-1 gene , 1997, Molecular and cellular biology.

[191] H. Mett,et al. Semicochliodinol A and B: inhibitors of HIV-1 protease and EGF-R protein tyrosine kinase related to asterriquinones produced by the fungus Chrysosporium merdarium. , 1997, The Journal of antibiotics.

[192] R. Liddington,et al. Raf-1 Kinase and Exoenzyme S Interact with 14-3-3ζ through a Common Site Involving Lysine 49* , 1997, The Journal of Biological Chemistry.

[193] T. Kim. In vitro transcriptional activation of p21 promoter by p53. , 1997, Biochemical and biophysical research communications.

[194] T. Hirano,et al. Tec tyrosine kinase links the cytokine receptors to PI-3 kinase probably through JAK , 1997, Oncogene.

[195] J C Reed,et al. Channel formation by antiapoptotic protein Bcl-2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[196] W. May,et al. Bcl-2 Phosphorylation Required for Anti-apoptosis Function* , 1997, The Journal of Biological Chemistry.

[197] P. Bucher,et al. The CARD domain: a new apoptotic signalling motif. , 1997, Trends in biochemical sciences.

[198] Yuri Lazebnik,et al. Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells , 1997, The EMBO journal.

[199] A. Yoshimura,et al. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. , 1997, Blood.

[200] J. McCubrey,et al. Regulation of interleukin 3 expression in normal and autocrine transformed hematopoietic cells (Review). , 1997, International journal of oncology.

[201] Anthony J. Muslin,et al. The protein kinase KSR interacts with 14-3-3 protein and Raf , 1997, Current Biology.

[202] Michael C. Ostrowski,et al. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1 , 1997, Molecular and cellular biology.

[203] John Calvin Reed,et al. Role of Bag-1 in the survival and proliferation of the cytokine-dependent lymphocyte lines, Ba/F3 and Nb2. , 1997, Molecular endocrinology.

[204] G. Krystal,et al. Interleukin-3 Induces the Association of the Inositol 5-Phosphatase SHIP with SHP2* , 1997, The Journal of Biological Chemistry.

[205] K. Ravichandran,et al. Shc Interaction with Src Homology 2 Domain Containing Inositol Phosphatase (SHIP) in Vivo Requires the Shc-Phosphotyrosine Binding Domain and Two Specific Phosphotyrosines on SHIP* , 1997, The Journal of Biological Chemistry.

[206] Xiaodong Wang,et al. DFF, a Heterodimeric Protein That Functions Downstream of Caspase-3 to Trigger DNA Fragmentation during Apoptosis , 1997, Cell.

[207] J. Cohen,et al. Calpain, an upstream regulator of thymocyte apoptosis. , 1997, Journal of immunology.

[208] S. Akira,et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[209] D. Morrison,et al. Mammalian Raf‐1 is activated by mutations that restore Raf signaling in Drosophila , 1997, The EMBO journal.

[210] P. Tsichlis,et al. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[211] J. Blenis,et al. Evidence for MEK-independent pathways regulating the prolonged activation of the ERK-MAP kinases , 1997, Oncogene.

[212] J. Tschopp,et al. Direct physical interaction between the Caenorhabditis elegans ‘death proteins’ CED‐3 and CED‐4 , 1997, FEBS letters.

[213] R. Kolesnick,et al. Kinase Suppressor of Ras Is Ceramide-Activated Protein Kinase , 1997, Cell.

[214] G. Nuovo,et al. Hyperexpression of mitogen-activated protein kinase in human breast cancer. , 1997, The Journal of clinical investigation.

[215] N. Inohara,et al. harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival‐promoting proteins Bcl‐2 and Bcl‐XL , 1997, The EMBO journal.

[216] J. Krosl,et al. The role of erythropoietin receptor tyrosine phosphorylation in erythropoietin-induced proliferation. , 1997, Leukemia.

[217] Y. Kitamura,et al. Mechanisms of constitutive activation of c-kit receptor tyrosine kinase. , 1997, Leukemia.

[218] D. Linch,et al. Analysis of the coding sequence for the GM-CSF receptor alpha and beta chains in patients with juvenile chronic myeloid leukemia (JCML). , 1997, Experimental hematology.

[219] C. Pihl,et al. Oligomerization of the soluble granulocyte-macrophage colony-stimulating factor receptor: identification of the functional ligand-binding species. , 1997, Cytokine.

[220] K. Welte,et al. Frequency of point mutations in the gene for the G‐CSF receptor in patients with chronic neutropenia undergoing G‐CSF therapy , 1997, Stem cells.

[221] K. Welte,et al. Clinical relevance of point mutations in the cytoplasmic domain of the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. , 1997, Blood.

[222] R. Maestro,et al. Human non-Hodgkin's lymphomas overexpress a wild-type form of p53 which is a functional transcriptional activator of the cyclin-dependent kinase inhibitor p21. , 1997, Blood.

[223] A. Fraser,et al. CED-4 induces chromatin condensation in Schizosaccharomyces pombe and is inhibited by direct physical association with CED-9 , 1997, Current Biology.

[224] J L Cleveland,et al. Pivotal role for the NFIL3/E4BP4 transcription factor in interleukin 3-mediated survival of pro-B lymphocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[225] W. Earnshaw,et al. Activation of Multiple Interleukin-1β Converting Enzyme Homologues in Cytosol and Nuclei of HL-60 Cells during Etoposide-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[226] V. Dixit,et al. Fas-associated Death Domain Protein Interleukin-1β-converting Enzyme 2 (FLICE2), an ICE/Ced-3 Homologue, Is Proximally Involved in CD95- and p55-mediated Death Signaling* , 1997, The Journal of Biological Chemistry.

[227] J. Cidlowski,et al. Native Recombinant Cyclophilins A, B, and C Degrade DNA Independently of Peptidylprolyl cis-trans-Isomerase Activity , 1997, The Journal of Biological Chemistry.

[228] Z. Fuks,et al. Stress-induced apoptosis and the sphingomyelin pathway. , 1997, Biochemical pharmacology.

[229] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.

[230] A. Lloyd,et al. Cooperating oncogenes converge to regulate cyclin/cdk complexes. , 1997, Genes & development.

[231] J. McCubrey,et al. Abnormal activation of cytokine gene expression by intracisternal type A particle transposition: effects of mutations that result in autocrine growth stimulation and malignant transformation. , 1997, Cytokines, cellular & molecular therapy.

[232] R. Schultz,et al. Characterization of Downstream Ras Signals That Induce Alternative Protease-dependent Invasive Phenotypes* , 1997, The Journal of Biological Chemistry.

[233] K. Kajiwara,et al. Possible Role of Nuclear Factor-κB Activity in Germline Cϵ Transcription in a Human Burkitt Lymphoma B Cell Line , 1997 .

[234] Dean P. Jones,et al. Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked , 1997, Science.

[235] G. Núñez,et al. Interaction and Regulation of Subcellular Localization of CED-4 by CED-9 , 1997, Science.

[236] A. Chinnaiyan,et al. Interaction of CED-4 with CED-3 and CED-9: A Molecular Framework for Cell Death , 1997, Science.

[237] D. Green,et al. The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.

[238] J. Massagué,et al. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. , 1997, Genes & development.

[239] Y. Kaziro,et al. Ras-dependent Activation of c-Jun N-terminal Kinase/Stress-activated Protein Kinase in Response to Interleukin-3 Stimulation in Hematopoietic BaF3 Cells* , 1997, The Journal of Biological Chemistry.

[240] Daniel J. Hoeppner,et al. Interaction between the C. elegans cell-death regulators CED-9 and CED-4 , 1997, Nature.

[241] S. Nagata,et al. Apoptosis by Death Factor , 1997, Cell.

[242] S. Barry,et al. Roles of the N and C Terminal Domains of the Interleukin-3 Receptor α Chain in Receptor Function , 1997 .

[243] G. Cooper,et al. Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase , 1997, Molecular and cellular biology.

[244] R. Jove,et al. Constitutive Activation of JAK1 in Src-transformed Cells* , 1997, The Journal of Biological Chemistry.

[245] Andy J. Minn,et al. Bcl-xL forms an ion channel in synthetic lipid membranes , 1997, Nature.

[246] K. Pumiglia,et al. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[247] G. Evan,et al. Inhibition of Ced-3/ICE-related Proteases Does Not Prevent Cell Death Induced by Oncogenes, DNA Damage, or the Bcl-2 Homologue Bak , 1997, The Journal of cell biology.

[248] S. Anderson,et al. Phosphorylation of Cbl following Stimulation with Interleukin-3 and Its Association with Grb2, Fyn, and Phosphatidylinositol 3-Kinase* , 1997, The Journal of Biological Chemistry.

[249] J. Pines,et al. Cyclin/Cdk-Dependent Initiation of DNA Replication in a Human Cell-Free System , 1997, Cell.

[250] Z. Hao,et al. Evidence supporting a signal transduction pathway leading to the radiation-resistant phenotype in human tumor cells. , 1997, Biochemical and biophysical research communications.

[251] M. Al‐Rubeai,et al. G2 cell cycle arrest and apoptosis are induced in Burkitt's lymphoma cells by the anticancer agent oracin , 1997, FEBS letters.

[252] R A Mufson,et al. The role of serine/threonine phosphorylation in hematopoietic cytokine receptor signal transduction , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[253] L. Rohrschneider,et al. Growth and differentiation signals regulated by the M‐CSF receptor , 1997, Molecular reproduction and development.

[254] T. Whiteside,et al. Correlation of constitutive activation of raf‐1 with morphological transformation and abrogation of tyrosine phosphorylation of distinct sets of proteins in human squamous carcinoma cells , 1997, Molecular carcinogenesis.

[255] J. Backer,et al. Specific activation of p85-p110 phosphatidylinositol 3'-kinase stimulates DNA synthesis by ras- and p70 S6 kinase-dependent pathways , 1997, Molecular and cellular biology.

[256] R. Müller,et al. Cell-cycle regulation of gene expression by transcriptional repression. , 1997, Trends in genetics : TIG.

[257] G. Goodall,et al. Roles of the N and C terminal domains of the interleukin-3 receptor alpha chain in receptor function. , 1997, Blood.

[258] J. Troppmair,et al. Apoptosis regulation by Raf, Bcl-2, and R-Ras. , 1997, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[259] M. Williams,et al. Analysis of the cyclin-dependent kinase inhibitors p18 and p19 in mantle-cell lymphoma and chronic lymphocytic leukemia. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[260] M. McMahon,et al. Identification of immediate-early gene targets of the Raf-1 serine/threonine protein kinase using an estradiol-dependent fusion protein, delta Raf-1:ER. , 1997, Methods in molecular biology.

[261] F. Caponigro,et al. Protein kinase C: a worthwhile target for anticancer drugs? , 1997, Anti-cancer drugs.

[262] M. Loda,et al. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[263] K. Kajiwara,et al. Possible role of nuclear factor-kappa B activity in germline C epsilon transcription in a human Burkitt lymphoma B cell line. , 1997, Cellular immunology.

[264] D. Scherman,et al. Synthesis and conformational analysis of peptide inhibitors of farnesyltransferase. , 1997, Bioorganic & medicinal chemistry.

[265] C. Begley,et al. The structural basis of the biological actions of the GM-CSF receptor. , 1997, Ciba Foundation symposium.

[266] W. Kolch,et al. Protein kinase C-epsilon associates with the Raf-1 kinase and induces the production of growth factors that stimulate Raf-1 activity. , 1997, Oncogene.

[267] J. Savill,et al. Recognition and phagocytosis of cells undergoing apoptosis. , 1997, British medical bulletin.

[268] W. Paul. Interleukin 4: signalling mechanisms and control of T cell differentiation. , 1997, Ciba Foundation symposium.

[269] D. Franklin,et al. Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6. , 1997, Immunity.

[270] V. Diehl,et al. The emerging role of immunotoxins in leukemia and lymphoma. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[271] J. Tschopp,et al. Characterization of two receptors for TRAIL. , 1997, FEBS letters.

[272] J. Gibbs,et al. The potential of farnesyltransferase inhibitors as cancer chemotherapeutics. , 1997, Annual review of pharmacology and toxicology.

[273] P. Hoodless,et al. MADR2 Is a Substrate of the TGFβ Receptor and Its Phosphorylation Is Required for Nuclear Accumulation and Signaling , 1996, Cell.

[274] U. Siebenlist,et al. Activation of nuclear factor-kappaB via T cell receptor requires a Raf kinase and Ca2+ influx. Functional synergy between Raf and calcineurin. , 1996, Journal of immunology.

[275] P. Lamb,et al. Multiple signaling pathways induced by granulocyte colony-stimulating factor involving activation of JAKs, STAT5, and/or STAT3 are required for regulation of three distinct classes of immediate early genes. , 1996, Blood.

[276] J. Xiang,et al. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[277] T Pawson,et al. Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[278] H. Greulich,et al. Mek1 Phosphorylation Site Mutants Activate Raf-1 in NIH 3T3 Cells* , 1996, The Journal of Biological Chemistry.

[279] R. V. van Etten,et al. P210 and P190BCR/ABL Induce the Tyrosine Phosphorylation and DNA Binding Activity of Multiple Specific STAT Family Members* , 1996, The Journal of Biological Chemistry.

[280] J. Cambier,et al. The SHIP phosphatase becomes associated with Fc gammaRIIB1 and is tyrosine phosphorylated during 'negative' signaling. , 1996, Immunology letters.

[281] Raymond J. Andersen,et al. Cytotoxic peptides hemiasterlin, hemiasterlin A and hemiasterlin B induce mitotic arrest and abnormal spindle formation , 1996, Cancer Chemotherapy and Pharmacology.

[282] S. Fenu,et al. Stem cell factor and PIXY-321 in acute lymphoblastic leukemia: in vitro study on proliferative effects and apoptosis. , 1996, Cytokines and molecular therapy.

[283] A. Wittinghofer,et al. How Ras-related proteins talk to their effectors. , 1996, Trends in biochemical sciences.

[284] J. Bartek,et al. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. , 1996, Cancer research.

[285] G. Nicolson,et al. Effect of PD 098059, a specific inhibitor of mitogen-activated protein kinase kinase, on urokinase expression and in vitro invasion. , 1996, Cancer research.

[286] S. Ratnofsky,et al. Proteolytic Activation of Protein Kinase C ␦ by an Ice/ced 3-like Protease Induces Characteristics of Apoptosis Materials and Methods , 1996 .

[287] J. Rowley,et al. Myeloid leukemia after hematotoxins. , 1996, Environmental health perspectives.

[288] Keisuke Kuida,et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice , 1996, Nature.

[289] J. Woodgett,et al. Mammalian Mitogen-activated Protein Kinase Pathways Are Regulated through Formation of Specific Kinase-Activator Complexes* , 1996, The Journal of Biological Chemistry.

[290] C. Milliman,et al. BID: a novel BH3 domain-only death agonist. , 1996, Genes & development.

[291] Elizabeth Yang,et al. Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL , 1996, Cell.

[292] C. Thompson,et al. Apoptosis Meets Signal Transduction: Elimination of a BAD Influence , 1996, Cell.

[293] John Calvin Reed,et al. Bcl-2 Targets the Protein Kinase Raf-1 to Mitochondria , 1996, Cell.

[294] T. Hoang,et al. A Dominant Negative Granulocyte-Macrophage Colony-stimulating Factor Receptor α Chain Reveals the Multimeric Structure of the Receptor Complex* , 1996, The Journal of Biological Chemistry.

[295] R. Siebert,et al. Role of the cyclin-dependent kinase 4 and 6 inhibitor gene family p15, p16, p18 and p19 in leukemia and lymphoma. , 1996, Leukemia & lymphoma.

[296] J. Ihle,et al. Naturally occurring dominant negative variants of Stat5 , 1996, Molecular and cellular biology.

[297] M. Loda,et al. Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. , 1996, The American journal of pathology.

[298] B. Berk,et al. Angiotensin II stimulates MAP kinase kinase kinase activity in vascular smooth muscle cells, Role of Raf. , 1996, Circulation research.

[299] Guido Kroemer,et al. Mitochondria and programmed cell death: back to the future , 1996, FEBS letters.

[300] S. Cook,et al. The Selective Protein Kinase C Inhibitor, Ro-31-8220, Inhibits Mitogen-activated Protein Kinase Phosphatase-1 (MKP-1) Expression, Induces c-Jun Expression, and Activates Jun N-terminal Kinase* , 1996, The Journal of Biological Chemistry.

[301] P. Jones,et al. Atypical isoforms of pKc and insulin secretion from pancreatic beta-cells: evidence using Gö 6976 and Ro 31-8220 as Pkc inhibitors. , 1996, Biochemical and biophysical research communications.

[302] Junying Yuan,et al. Human ICE/CED-3 Protease Nomenclature , 1996, Cell.

[303] K. Xia,et al. The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent manner. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[304] S. Akira,et al. Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. , 1996, Journal of immunology.

[305] A. Hayday,et al. Raf regulates positive selection , 1996, European journal of immunology.

[306] A. Dutra,et al. Genomic sequence, organization, and chromosomal localization of human JAK3. , 1996, Genomics.

[307] D. Vaux,et al. CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO‐1)‐transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. , 1996, The EMBO journal.

[308] P. Iversen,et al. Inhibition of proliferation and induction of apoptosis in juvenile myelomonocytic leukemic cells by the granulocyte-macrophage colony-stimulating factor analogue E21R. , 1996, Blood.

[309] A. Hakura,et al. Abrogation of c-kit/Steel factor-dependent tumorigenesis by kinase defective mutants of the c-kit receptor: c-kit kinase defective mutants as candidate tools for cancer gene therapy. , 1996, Cancer research.

[310] S. Nagata,et al. Apoptosis: Telling cells their time is up , 1996, Current Biology.

[311] M Mabry,et al. RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas , 1996, Molecular and cellular biology.

[312] R. Nishinakamura,et al. Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions. , 1996, Blood.

[313] T. Golub,et al. p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines. , 1996, Oncogene.

[314] P. J. Belshaw,et al. Oligomerization activates c-Raf-1 through a Ras-dependent mechanism , 1996, Nature.

[315] M. Farrar,et al. Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization , 1996, Nature.

[316] R. Derynck,et al. Receptor-associated Mad homologues synergize as effectors of the TGF-β response , 1996, Nature.

[317] C. Marshall. Raf gets it together , 1996, Nature.

[318] J. Bertin,et al. Apoptotic suppression by baculovirus P35 involves cleavage by and inhibition of a virus-induced CED-3/ICE-like protease , 1996, Journal of virology.

[319] J. Pouysségur,et al. Cyclin D1 Expression Is Regulated Positively by the p42/p44MAPK and Negatively by the p38/HOGMAPK Pathway* , 1996, The Journal of Biological Chemistry.

[320] Michael E. Greenberg,et al. Coupling of the RAS-MAPK Pathway to Gene Activation by RSK2, a Growth Factor-Regulated CREB Kinase , 1996, Science.

[321] N. Miyasaka,et al. An Epidermal Growth Factor Receptor/Jak2 Tyrosine Kinase Domain Chimera Induces Tyrosine Phosphorylation of Stat5 and Transduces a Growth Signal in Hematopoietic Cells* , 1996, The Journal of Biological Chemistry.

[322] H. Mott,et al. The solution structure of the Raf-1 cysteine-rich domain: a novel ras and phospholipid binding site. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[323] Y. Lazebnik,et al. Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[324] W. Leonard. Dysfunctional cytokine receptor signaling in severe combined immunodeficiency. , 1996, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[325] T. Cotter,et al. Oxidative stress and apoptosis in neurodegeneration , 1996, Journal of the Neurological Sciences.

[326] D. Chan,et al. Interleukin-1 beta-converting enzyme-like protease cleaves DNA- dependent protein kinase in cytotoxic T cell killing , 1996, The Journal of experimental medicine.

[327] T. Golub,et al. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia , 1996, Molecular and cellular biology.

[328] F. Su,et al. Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases , 1996, Journal of virology.

[329] S. Srinivasula,et al. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[330] E. Gelfand,et al. p70 S6 kinase sensitivity to rapamycin is eliminated by amino acid substitution of Thr229. , 1996, Journal of immunology.

[331] S. Korsmeyer,et al. Molecular thanatopsis: a discourse on the BCL2 family and cell death. , 1996, Blood.

[332] A. Chinnaiyan,et al. The CED-3/ICE-like Protease Mch2 Is Activated during Apoptosis and Cleaves the Death Substrate Lamin A* , 1996, The Journal of Biological Chemistry.

[333] A. Chinnaiyan,et al. ICE-LAP6, a Novel Member of the ICE/Ced-3 Gene Family, Is Activated by the Cytotoxic T Cell Protease Granzyme B* , 1996, The Journal of Biological Chemistry.

[334] Xiaodong Wang,et al. Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.

[335] John Calvin Reed,et al. Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[336] S. Oldham,et al. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[337] A. Hatzigeorgiou,et al. Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter , 1996, Molecular and cellular biology.

[338] M. Wigler,et al. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation , 1996, Molecular and cellular biology.

[339] J. Zhang,et al. Transcriptional regulation of interleukin-3 expression in megakaryocytes. , 1996, Blood.

[340] A. Chinnaiyan,et al. Cytotoxic T-cell-derived granzyme B activates the apoptotic protease ICE-LAP3 , 1996, Current Biology.

[341] J. Pouysségur,et al. Oncogenic Raf-1 Activates p70 S6 Kinase via a Mitogen-activated Protein Kinase-independent Pathway* , 1996, The Journal of Biological Chemistry.

[342] Bert Vogelstein,et al. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21 , 1996, Nature.

[343] J. Laubach,et al. Cooperation between Core Binding Factor and Adjacent Promoter Elements Contributes to the Tissue-specific Expression of Interleukin-3* , 1996, The Journal of Biological Chemistry.

[344] David Wallach,et al. Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death , 1996, Cell.

[345] Matthias Mann,et al. FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.

[346] C. Thompson,et al. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. , 1996, The EMBO journal.

[347] M. F. Shannon,et al. Costimulation of cytokine gene expression in T cells by the human T leukemia/lymphotropic virus type 1 trans activator Tax , 1996, Journal of virology.

[348] K. Bauer,et al. Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA , 1996, Current Biology.

[349] Bart,et al. Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit , 1996, Molecular and cellular biology.

[350] G. Goodall,et al. Human interleukin-3 (IL-3) induces disulfide-linked IL-3 receptor alpha- and beta-chain heterodimerization, which is required for receptor activation but not high-affinity binding , 1996, Molecular and cellular biology.

[351] Xiaozhong Wang,et al. Stress-Induced Phosphorylation and Activation of the Transcription Factor CHOP (GADD153) by p38 MAP Kinase , 1996, Science.

[352] T. Ishizuka,et al. Aggregation of the FcepsilonRI on mast cells stimulates c-Jun amino-terminal kinase activity. A response inhibited by wortmannin. , 1996, The Journal of biological chemistry.

[353] C. Demaria,et al. AUF1 Binding Affinity to A+U-rich Elements Correlates with Rapid mRNA Degradation (*) , 1996, The Journal of Biological Chemistry.

[354] J. C. Pratt,et al. Evidence for a Physical Association between the Shc-PTB Domain and the βc Chain of the Granulocyte-Macrophage Colony-stimulating Factor Receptor (*) , 1996, The Journal of Biological Chemistry.

[355] C. Baum,et al. Combination therapy for radiation-induced bone marrow aplasia in nonhuman primates using synthokine SC-55494 and recombinant human granulocyte colony-stimulating factor. , 1996, Blood.

[356] D. Vaux,et al. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[357] L. Sachs,et al. The control of hematopoiesis and leukemia: from basic biology to the clinic. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[358] W. J. Pledger,et al. Differential Modulation of G Cyclins and the Cdk Inhibitor p27 by Platelet-derived Growth Factor and Plasma Factors in Density-arrested Fibroblasts (*) , 1996, The Journal of Biological Chemistry.

[359] M. Su,et al. Processing and Activation of CMH-1 by Granzyme B (*) , 1996, The Journal of Biological Chemistry.

[360] L. Rohrschneider,et al. p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. , 1996, Genes & development.

[361] Z. Darżynkiewicz,et al. Unscheduled expression of cyclins D1 and D3 in human tumour cell lines , 1996, Cell proliferation.

[362] M. Collins,et al. The role of MAP kinase kinase in interleukin-3 stimulation of proliferation. , 1996, Blood.

[363] C. Pritchard,et al. Post-natal lethality and neurological and gastrointestinal defects in mice with targeted disruption of the A-Raf protein kinase gene , 1996, Current Biology.

[364] U. Rapp,et al. Regulation of A-raf expression. , 1996, Oncogene.

[365] S. Akira,et al. Essential role of Stat6 in IL-4 signalling , 1996, Nature.

[366] A. Strasser,et al. Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[367] W. El-Deiry,et al. Regulation of p21WAF1/CIP1 expression by p53-independent pathways. , 1996, Oncogene.

[368] G. Yancopoulos,et al. Differential activation of the extracellular signal‐regulated kinase, Jun Kinase and Janus Kinase‐Stat pathways by oncostatin M and basic fibroblast growth factor in AIDS‐derived Kaposi's sarcoma cells , 1996, AIDS.

[369] C. Begley,et al. Functional inactivation in mice of the gene for the interleukin-3 (IL-3)-specific receptor beta-chain: implications for IL-3 function and the mechanism of receptor transmodulation in hematopoietic cells. , 1996, Blood.

[370] S. Spiegel,et al. Signal transduction through lipid second messengers. , 1996, Current opinion in cell biology.

[371] H. Drexler,et al. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells. , 1996, Leukemia.

[372] J. McCubrey,et al. Malignant transformation induced by cytokine genes: a comparison of the abilities of germline and mutated interleukin 3 genes to transform hematopoietic cells by transcriptional and posttranscriptional mechanisms. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[373] G. Mills,et al. Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils , 1996, The Journal of experimental medicine.

[374] G. Kroemer,et al. Mitochondrial control of nuclear apoptosis , 1996, The Journal of experimental medicine.

[375] K. Arai,et al. Granulocyte-macrophage Colony-stimulating Factor Provokes RAS Activation and Transcription of c-fos through Different Modes of Signaling (*) , 1996, The Journal of Biological Chemistry.

[376] P. Allen,et al. Interaction of 14-3-3 with Signaling Proteins Is Mediated by the Recognition of Phosphoserine , 1996, Cell.

[377] R. Weinberg,et al. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. , 1996, Oncogene.

[378] L. Gold,et al. Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. , 1996, The Journal of clinical investigation.

[379] C. Croce,et al. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. , 1996, Cancer research.

[380] G. Salvesen,et al. Proteolytic activation of the cell death protease Yama/CPP32 by granzyme B. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[381] J. Blenis,et al. Evidence for two catalytically active kinase domains in pp90rsk , 1996, Molecular and cellular biology.

[382] Philip R. Cohen,et al. Cellular stresses and cytokines activate multiple mitogen-activated-protein kinase kinase homologues in PC12 and KB cells. , 1996, European journal of biochemistry.

[383] M. Kaplan,et al. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. , 1996, Immunity.

[384] J. Wands,et al. Overexpression of human insulin receptor substrate 1 induces cellular transformation with activation of mitogen-activated protein kinases , 1996, Molecular and cellular biology.

[385] W. Leonard,et al. Importance of low affinity Elf-1 sites in the regulation of lymphoid- specific inducible gene expression , 1996, The Journal of experimental medicine.

[386] P. Warne,et al. Phosphatidylinositol 3' kinase: one of the effectors of Ras. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[387] P. Majerus,et al. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[388] A. Levitzki,et al. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor , 1996, Nature.

[389] L. Zon,et al. Signal Transduction Pathways Regulated by Mitogen-activated/Extracellular Response Kinase Kinase Kinase Induce Cell Death (*) , 1996, The Journal of Biological Chemistry.

[390] D. Levy,et al. Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease , 1996, Cell.

[391] C. Walsh,et al. Differential functions of the two Src homology 2 domains in protein tyrosine phosphatase SH-PTP1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[392] D. Faller,et al. Phosphorylation of Bcl-2 Protein and Association with p21Ras in Ras-induced Apoptosis (*) , 1996, The Journal of Biological Chemistry.

[393] T. Saida,et al. Immunohistochemical detection of CDK4 and 9 16INK4 proteins in cutaneous malignant melanoma , 1996, The British journal of dermatology.

[394] C. Rommel,et al. Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1. , 1996, Oncogene.

[395] John Calvin Reed,et al. A1, a Bcl-2 family member, prolongs cell survival and permits myeloid differentiation. , 1996, Blood.

[396] S. Arkins,et al. Requirement for phosphatidylinositol 3'-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor. , 1996, Journal of immunology.

[397] D. Largaespada,et al. Nf1 deficiency causes Ras-Dediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia , 1996, Nature Genetics.

[398] A. Deblasio,et al. Formation of p27-CDK complexes during the human mitotic cell cycle. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[399] K. Tamai,et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes , 1996, Nature.

[400] C. Baum,et al. Acceleration of hematopoietic reconstitution with a synthetic cytokine (SC-55494) after radiation-induced bone marrow aplasia. , 1996, Blood.

[401] C. Petritsch,et al. Cell Cycle Regulation of p70 S6 Kinase and p42/p44 Mitogen-activated Protein Kinases in Swiss Mouse 3T3 Fibroblasts (*) , 1996, The Journal of Biological Chemistry.

[402] J. Balligand,et al. Regulation of Cytokine-inducible Nitric Oxide Synthase in Cardiac Myocytes and Microvascular Endothelial Cells , 1996, The Journal of Biological Chemistry.

[403] K. Izuhara,et al. Signal Transduction Pathway of Interleukin-4 and Interleukin-13 in Human B Cells Derived from X-linked Severe Combined Immunodeficiency Patients (*) , 1996, The Journal of Biological Chemistry.

[404] M. White,et al. Ras Interaction with Two Distinct Binding Domains in Raf-1 5 Be Required for Ras Transformation (*) , 1996, The Journal of Biological Chemistry.

[405] Y. Wang,et al. Regulation of the cell cycle machinery by oncogenic ras. , 1996, Oncogene.

[406] J C Reed,et al. Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death. , 1996, Advances in experimental medicine and biology.

[407] J. Roth,et al. Antisense regulation of oncogenes in human cancer. , 1996, Critical reviews in oncogenesis.

[408] John Calvin Reed,et al. BCL‐2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy , 1996, Journal of cellular biochemistry.

[409] H. Hirsch,et al. Impaired interleukin-3 mRNA decay in autocrine mast cell tumors after transient calcium ionophore stimulation. , 1996, Growth factors.

[410] J. Gamble,et al. Monoclonal antibody 7G3 recognizes the N-terminal domain of the human interleukin-3 (IL-3) receptor alpha-chain and functions as a specific IL-3 receptor antagonist. , 1996, Blood.

[411] A. Nordheim,et al. Signalling pathways: Jack of all cascades , 1996, Current Biology.

[412] T. Hunter,et al. JAK2, Ras, and Raf Are Required for Activation of Extracellular Signal-regulated Kinase/Mitogen-activated Protein Kinase by Growth Hormone (*) , 1995, The Journal of Biological Chemistry.

[413] S. Yokoyama,et al. Cysteine-rich Region of Raf-1 Interacts with Activator Domain of Post-translationally Modified Ha-Ras (*) , 1995, The Journal of Biological Chemistry.

[414] Monika Tsai-Pflugfelder,et al. A proline-rich TGF-beta-responsive transcriptional activator interacts with histone H3. , 1995, Genes & development.

[415] T. Hambuch,et al. The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[416] S. Nadler,et al. Elucidating the Mechanism of Action of the Immunosuppressant 15‐Deoxyspergualin , 1995, Therapeutic drug monitoring.

[417] D. Morrison. Mechanisms regulating Raf‐1 activity in signal transduction pathways , 1995, Molecular reproduction and development.

[418] M. Marshall. Interactions between Ras and Raf: Key regulatory proteins in cellular transformation , 1995, Molecular Reproduction and Development.

[419] R. Weichselbaum,et al. Proteolytic activation of protein kinase C delta by an ICE‐like protease in apoptotic cells. , 1995, The EMBO journal.

[420] A. Strasser,et al. Bcl‐2 and Fas/APO‐1 regulate distinct pathways to lymphocyte apoptosis. , 1995, The EMBO journal.

[421] M. Diaz-Meco,et al. Evidence for a role of MEK and MAPK during signal transduction by protein kinase C zeta. , 1995, The EMBO journal.

[422] Roger J. Davis,et al. Transcriptional regulation by MAP kinases , 1995, Molecular reproduction and development.

[423] M. Merino,et al. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions , 1995, Nature Medicine.

[424] Philip R. Cohen,et al. PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*) , 1995, The Journal of Biological Chemistry.

[425] M. Jücker,et al. Identification of a New Adapter Protein That May Link the Common β Subunit of the Receptor for Granulocyte/Macrophage Colony-stimulating Factor, Interleukin (IL)-3, and IL-5 to Phosphatidylinositol 3-Kinase (*) , 1995, The Journal of Biological Chemistry.

[426] R. Kolesnick,et al. Phosphorylation of Raf by ceramide-activated protein kinase , 1995, Nature.

[427] N. Rosen,et al. A peptidomimetic inhibitor of farnesyl:protein transferase blocks the anchorage-dependent and -independent growth of human tumor cell lines. , 1995, Cancer research.

[428] C. Schneider,et al. Microfilament reorganization during apoptosis: the role of Gas2, a possible substrate for ICE‐like proteases. , 1995, The EMBO journal.

[429] C. Pritchard,et al. Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells , 1995, Molecular and cellular biology.

[430] T. Chittenden,et al. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. , 1995, The EMBO journal.

[431] E. Brambilla,et al. Differential c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma of the head and neck: implication in drug and radioresistance. , 1995, European journal of cancer. Part B, Oral oncology.

[432] P. Cohen,et al. The activation of distinct mitogen-activated protein kinase cascades is required for the stimulation of 2-deoxyglucose uptake by interleukin-1 and insulin-like growth factor-1 in KB cells. , 1995, The Biochemical journal.

[433] Wei Zhang,et al. Molecular cloning and characterization of NF-IL3A, a transcriptional activator of the human interleukin-3 promoter , 1995, Molecular and cellular biology.

[434] L. Neckers,et al. Taxol induction of p21WAF1 and p53 requires c-raf-1. , 1995, Cancer research.

[435] J. McCubrey,et al. Synergy between AUUUA motif disruption and enhancer insertion results in autocrine transformation of interleukin-3-dependent hematopoietic cells. , 1995, Blood.

[436] J. Downing,et al. Molecular cloning, expression pattern, and chromosomal localization of human CDKN2D/INK4d, an inhibitor of cyclin D-dependent kinases. , 1995, Genomics.

[437] C. Begley,et al. Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[438] C. Albanese,et al. Transforming p21ras Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions (*) , 1995, The Journal of Biological Chemistry.

[439] J C Reed,et al. The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2. , 1995, Oncogene.

[440] N. Dibb,et al. Selection of activating mutations of c-fms in FDC-P1 cells. , 1995, Oncogene.

[441] D. Nicholson,et al. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B , 1995, Nature.

[442] J. McCubrey,et al. Changes in glucose-transport associated with malignant transformation (review). , 1995, International journal of oncology.

[443] R. Lucito,et al. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. , 1995, The EMBO journal.

[444] H. Schaeffer,et al. A proline-rich sequence unique to MEK1 and MEK2 is required for raf binding and regulates MEK function , 1995, Molecular and cellular biology.

[445] H. Kijima,et al. Oligonucleotide‐mediated modulation of mammalian gene expression 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[446] N. Danial,et al. Jak-STAT signaling induced by the v-abl oncogene. , 1995, Science.

[447] W. Telford,et al. CrmA, a Poxvirus-encoded Serpin, Inhibits Cytotoxic T-lymphocyte-mediated Apoptosis (*) , 1995, The Journal of Biological Chemistry.

[448] Y. Lazebnik,et al. Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[449] E. Petricoin,et al. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. , 1995, Science.

[450] G. Krystal,et al. Identification and Characterization of an Interleukin-3 Receptor-associated 110-kDa Serine/Threonine Kinase (*) , 1995, The Journal of Biological Chemistry.

[451] M. Barinaga. Cell biology. Two major signaling pathways meet at MAP-kinase. , 1995, Science.

[452] H. Horvitz,et al. Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein , 1995, Nature.

[453] T. Hamaguchi,et al. RK‐682, a potent inhibitor of tyrosine phosphatase, arrested the mammalian cell cycle progression at G1phase , 1995, FEBS letters.

[454] O Yoshida,et al. Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. , 1995, Cancer research.

[455] J. Griffin,et al. Identification of a viability domain in the granulocyte/macrophage colony-stimulating factor receptor beta-chain involving tyrosine-750. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[456] D. Conte,et al. Deregulation of cyclin E in breast cancer. , 1995, Oncogene.

[457] Z. Darżynkiewicz,et al. Discrimination of G2 and mitotic cells by flow cytometry based on different expression of cyclins A and B1. , 1995, Experimental cell research.

[458] I. Weinstein,et al. Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors. , 1995, Carcinogenesis.

[459] T. Hunter,et al. Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. , 1995, Molecular biology of the cell.

[460] J. Stone,et al. RAS signalling is abnormal in a c-raf1 MEK1 double mutant , 1995, Molecular and cellular biology.

[461] H. Hirsch,et al. Interleukin-3 mRNA Stabilization by a trans-Acting Mechanism in Autocrine Tumors Lacking Interleukin-3 Gene Rearrangements (*) , 1995, The Journal of Biological Chemistry.

[462] J. McCubrey,et al. Autocrine growth-factor secretion after transformation of human cytokine-dependent cells by viral and cellular oncogenes. , 1995, International journal of oncology.

[463] M. Miura,et al. Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[464] Stephen J. Elledge,et al. Mice Lacking p21 CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control , 1995, Cell.

[465] K. Welte,et al. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. , 1995, The New England journal of medicine.

[466] J. Abraham,et al. Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes. , 1995, Genes & development.

[467] S. Anderson,et al. Activation of src-related tyrosine kinases by IL-3. , 1995, Journal of immunology.

[468] M. Yaqoob,et al. The role of cysteine proteases in hypoxia-induced rat renal proximal tubular injury. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[469] A. Bridges,et al. A synthetic inhibitor of the mitogen-activated protein kinase cascade. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[470] H. Koeffler,et al. Role of the cyclin-dependent kinase inhibitors in the development of cancer. , 1995, Blood.

[471] J. Nevins,et al. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes , 1995, Molecular and cellular biology.

[472] J. Frost,et al. MEKK1 phosphorylates MEK1 and MEK2 but does not cause activation of mitogen-activated protein kinase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[473] M. Zoratti,et al. The mitochondrial permeability transition. , 1995, Biochimica et biophysica acta.

[474] W. Leonard,et al. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. , 1995, Science.

[475] R. Weinberg,et al. Growth suppression by p16ink4 requires functional retinoblastoma protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[476] C. Marshall,et al. Ras recruits Raf‐1 to the plasma membrane for activation by tyrosine phosphorylation. , 1995, The EMBO journal.

[477] R. A. Mufson,et al. Human interleukin-3 receptor modulates bcl-2 mRNA and protein levels through protein kinase C in TF-1 cells. , 1995, Blood.

[478] B. Groner,et al. A target for tumour-directed therapy , 1995, Nature Medicine.

[479] S. Ng,et al. Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells , 1995, Molecular and cellular biology.

[480] J. Bartek,et al. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 , 1995, Nature.

[481] Xiao-Fan Wang,et al. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[482] Muneesh Tewari,et al. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase , 1995, Cell.

[483] G. Zon,et al. C-RAF-1 serine/threonine kinase is required in BCR/ABL-dependent and normal hematopoiesis. , 1995, Cancer research.

[484] Y. Shounan,et al. Transformation of FDC-P1 cells to IL-3 independence by a recombinant murine retrovirus containing v-erb-B. , 1995, Experimental hematology.

[485] N. Copeland,et al. A novel cytokine‐inducible gene CIS encodes an SH2‐containing protein that binds to tyrosine‐phosphorylated interleukin 3 and erythropoietin receptors. , 1995, The EMBO journal.

[486] K. Arai,et al. Characterization of cis-regulatory elements of the c-myc promoter responding to human GM-CSF or mouse interleukin 3 in mouse proB cell line BA/F3 cells expressing the human GM-CSF receptor. , 1995, Molecular biology of the cell.

[487] F. Ruscetti,et al. Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells , 1995, The Journal of experimental medicine.

[488] L. A. Burns,et al. Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway , 1995, Molecular and cellular biology.

[489] Arul M. Chinnaiyan,et al. FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis , 1995, Cell.

[490] R. Weinberg,et al. The retinoblastoma protein and cell cycle control , 1995, Cell.

[491] D N Shapiro,et al. Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4 , 1995, Molecular and cellular biology.

[492] James M. Roberts,et al. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition , 1995, Molecular and cellular biology.

[493] M. Roussel,et al. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6 , 1995, Molecular and cellular biology.

[494] P. Farnham,et al. v-Raf activates transcription of growth-responsive promoters via GC-rich sequences that bind the transcription factor Sp1. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[495] G. Mills,et al. Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro. , 1995, Cancer research.

[496] R. Alam,et al. The intracellular signal transduction mechanism of interleukin 5 in eosinophils: the involvement of lyn tyrosine kinase and the Ras-Raf-1- MEK-microtubule-associated protein kinase pathway , 1995, The Journal of experimental medicine.

[497] C. Der,et al. Two Distinct Raf Domains Mediate Interaction with Ras (*) , 1995, The Journal of Biological Chemistry.

[498] C. Baum,et al. Potent interleukin 3 receptor agonist with selectively enhanced hematopoietic activity relative to recombinant human interleukin 3. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[499] K. Kinzler,et al. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. , 1995, Genes & development.

[500] M. Karin,et al. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. , 1995, Science.

[501] J. Camonis,et al. A Novel Protein That Interacts with the Death Domain of Fas/APO1 Contains a Sequence Motif Related to the Death Domain (*) , 1995, The Journal of Biological Chemistry.

[502] John Calvin Reed. Bcl-2: prevention of apoptosis as a mechanism of drug resistance. , 1995, Hematology/oncology clinics of North America.

[503] H. Erdjument-Bromage,et al. Interleukin‐3 signals through multiple isoforms of Stat5. , 1995, The EMBO journal.

[504] S. Elledge,et al. Inhibition of cyclin-dependent kinases by p21. , 1995, Molecular biology of the cell.

[505] M. Su,et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. , 1995, Science.

[506] M. Weber,et al. Biochemical Analysis of MEK Activation in NIH3T3 Fibroblasts , 1995, The Journal of Biological Chemistry.

[507] K. M. Mulder,et al. Transforming Growth Factor β Activation of p44mapk in Proliferating Cultures of Epithelial Cells (*) , 1995, The Journal of Biological Chemistry.

[508] P. Rao,et al. A Membrane Proximal Domain of the Human Interleukin-3 Receptor βc Subunit That Signals DNA Synthesis in NIH 3T3 Cells Specifically Binds a Complex of Src and Janus Family Tyrosine Kinases and Phosphatidylinositol 3-Kinase (*) , 1995, The Journal of Biological Chemistry.

[509] M. Kasuga,et al. Normal activation of p70 S6 kinase by insulin in cells overexpressing dominant negative 85kD subunit of phosphoinositide 3-kinase. , 1995, Biochemical and biophysical research communications.

[510] P. Dent,et al. Suppression of growth factor-mediated MAP kinase activation by v-raf in macrophages: a putative role for the MKP-1 phosphatase. , 1995, Oncogene.

[511] K. Okazaki,et al. MAP kinase activation is essential for oncogenic transformation of NIH3T3 cells by Mos. , 1995, Oncogene.

[512] J. Massagué,et al. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. , 1995, Genes & development.

[513] S. Elledge,et al. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. , 1995, Genes & development.

[514] J. Darnell,et al. Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway , 1995, Science.

[515] R. Nishinakamura,et al. Mice deficient for the IL-3/GM-CSF/IL-5 βc receptor exhibit lung pathology and impaired immune response, while βIL3 receptor-deficient mice are normal , 1995 .

[516] L. Benítez-Bribiesca. [Apoptosis in the pathogenesis and treatment of disease]. , 1995, Gaceta medica de Mexico.

[517] D. Kessler,et al. Biochemical and biological analysis of Mek1 phosphorylation site mutants. , 1995, Molecular biology of the cell.

[518] M. Kastan,et al. Growth factor modulation of p53-mediated growth arrest versus apoptosis. , 1995, Genes & development.

[519] D. Mercola,et al. Antisense approaches to cancer gene therapy. , 1995, Cancer gene therapy.

[520] G. Hannon,et al. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD , 1995, Science.

[521] M. Tewari,et al. Fas- and Tumor Necrosis Factor-induced Apoptosis Is Inhibited by the Poxvirus crmA Gene Product (*) , 1995, The Journal of Biological Chemistry.

[522] R. Kamen,et al. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock , 1995, Cell.

[523] Jiahuai Han,et al. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms , 1995, Science.

[524] T. Hirano,et al. Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines. , 1995, Blood.

[525] S. Korsmeyer,et al. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death , 1995, Cell.

[526] C. Marshall,et al. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[527] A. Hakura,et al. An in vivo model for receptor tyrosine kinase autocrine/paracrine activation: auto-stimulated KIT receptor acts as a tumor promoting factor in papillomavirus-induced tumorigenesis. , 1995, Oncogene.

[528] R. DePinho,et al. Inhibition of ras-induced proliferation and cellular transformation by p16INK4 , 1995, Science.

[529] E. Kornilova,et al. EGF receptor and p185erbB‐2‐specific single‐chain antibody toxins differ in their cell‐killing activity on tumor cells expressing both receptor proteins , 1995, International journal of cancer.

[530] B. Druker,et al. Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GM‐CSF, IL‐3 and steel factor and is constitutively increased by p210BCR/ABL. , 1995, The EMBO journal.

[531] K. Arai,et al. Suppression of apoptotic death in hematopoietic cells by signalling through the IL‐3/GM‐CSF receptors. , 1995, The EMBO journal.

[532] John Calvin Reed,et al. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.

[533] W. Sellers,et al. Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter , 1994, Molecular and cellular biology.

[534] J. Ihle. Hematopoietic Signaling by the Cytokine Receptor Superfamily , 1995 .

[535] A. Miyajima,et al. a truncated beta C subunit . complete conversion to growth autonomy beta-subunit genes are necessary for the colony-stimulating factor / IL 5 receptor ( IL 3 ) / granulocyte-macrophage Sequential mutations in the interleukin-3 , 1995 .

[536] K O'Rourke,et al. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. , 1995, Cell.

[537] R. Fotedar,et al. Cell cycle control of DNA replication. , 1995, Progress in cell cycle research.

[538] W. Gelbart,et al. Genetic screens to identify elements of the decapentaplegic signaling pathway in Drosophila. , 1995, Genetics.

[539] D. Hossfeld,et al. Absence of point mutations in the extracellular domain of the alpha subunit of the GM-CSF receptor in a series of patients with acute myeloid leukemia (AML). , 1995, Leukemia.

[540] A. Zetterberg,et al. What is the restriction point? , 1995, Current opinion in cell biology.

[541] G. Majno,et al. Apoptosis, oncosis, and necrosis. An overview of cell death. , 1995, The American journal of pathology.

[542] K. Arai,et al. Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal. , 1995, Immunity.

[543] R. Müller,et al. Cell cycle-regulated transcription in mammalian cells. , 1995, Progress in cell cycle research.

[544] C. Walsh,et al. Intramolecular regulation of protein tyrosine phosphatase SH-PTP1: a new function for Src homology 2 domains. , 1994, Biochemistry.

[545] B. Margolis,et al. A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors. , 1994, The Journal of biological chemistry.

[546] L. Zon,et al. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1 , 1994, Nature.

[547] L. Hartwell,et al. Cell cycle control and cancer. , 1994, Science.

[548] L. Williams,et al. An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. , 1994, Science.

[549] C. O'keefe,et al. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. , 1994, Genes & development.

[550] G L Johnson,et al. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. , 1994, Science.

[551] L. Wiedemann,et al. A temperature sensitive p210 BCR‐ABL mutant defines the primary consequences of BCR‐ABL tyrosine kinase expression in growth factor dependent cells. , 1994, The EMBO journal.

[552] E. Lam,et al. DP and E2F proteins: coordinating transcription with cell cycle progression. , 1994, Current opinion in cell biology.

[553] M. McMahon,et al. Inhibition of platelet-derived growth factor- and epidermal growth factor-mediated mitogenesis and signaling in 3T3 cells expressing delta Raf-1:ER, an estradiol-regulated form of Raf-1 , 1994, Molecular and cellular biology.

[554] A. Robles,et al. Induction of cyclin D1 overexpression by activated ras. , 1994, Oncogene.

[555] U. Strausfeld,et al. Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision—repair , 1994, Current Biology.

[556] M. Weber,et al. Partial purification of a mitogen-activated protein kinase kinase activator from bovine brain. Identification as B-Raf or a B-Raf-associated activity. , 1994, The Journal of biological chemistry.

[557] G. Stoecklin,et al. Functional hierarchy of AUUUA motifs in mediating rapid interleukin-3 mRNA decay. , 1994, The Journal of biological chemistry.

[558] K. Shannon,et al. Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras , 1994 .

[559] B. Desoize. Anticancer drug resistance and inhibition of apoptosis. , 1994, Anticancer research.

[560] S. Stabel,et al. Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro. , 1994, Oncogene.

[561] V. Calvo,et al. Activation of 70‐kDa S6 kinase, induced by the cytokines interleukin‐3 and erythropoietin and inhibited by rapamycin, is not an absolute requirement for cell proliferation , 1994, European journal of immunology.

[562] J. Troppmair,et al. The ins and outs of Raf kinases. , 1994, Trends in biochemical sciences.

[563] D. Cockayne,et al. Transgenic mice expressing antisense interleukin-3 RNA develop a B-cell lymphoproliferative syndrome or neurologic dysfunction. , 1994, Blood.

[564] E. Krebs,et al. Overexpression of mitogen-activated protein kinase kinase (MAPKK) and its mutants in NIH 3T3 cells. Evidence that MAPKK involvement in cellular proliferation is regulated by phosphorylation of serine residues in its kinase subdomains VII and VIII. , 1994, The Journal of biological chemistry.

[565] K. Xia,et al. Interaction of the protein kinase Raf-1 with 14-3-3 proteins. , 1994, Science.

[566] G. Hannon,et al. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair , 1994, Nature.

[567] G. Landreth,et al. The mitogen-activated protein kinase cascade is activated by B-Raf in response to nerve growth factor through interaction with p21ras , 1994, Molecular and cellular biology.

[568] C. Der,et al. Expression of activated RAF accelerates cell differentiation and RB protein down-regulation but not hypophosphorylation. , 1994, European journal of cell biology.

[569] C. Begley,et al. No evidence for GM-CSF receptor alpha chain gene mutation in AML-M2 leukemias which have lost a sex chromosome. , 1994, Leukemia.

[570] M. F. Shannon,et al. T-cell functional regions of the human IL-3 proximal promoter. , 1994, Molecular reproduction and development.

[571] S. Aaronson,et al. Oncogenic activation of human R-ras by point mutations analogous to those of prototype H-ras oncogenes. , 1994, Oncogene.

[572] F. McCormick,et al. Binding of 14-3-3 proteins to the protein kinase Raf and effects on its activation. , 1994, Science.

[573] C. Harris,et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.

[574] G. Peters. Stifled by inhibitions , 1994, Nature.

[575] R. Takahashi,et al. Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification. , 1994, Journal of the National Cancer Institute.

[576] G. Johnson,et al. Ras-dependent growth factor regulation of MEK kinase in PC12 cells. , 1994, Science.

[577] S. Krajewski,et al. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. , 1994, Oncogene.

[578] Gregory J. Hannon,et al. pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest , 1994, Nature.

[579] S. Elledge,et al. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[580] N. Ahn,et al. Transformation of mammalian cells by constitutively active MAP kinase kinase. , 1994, Science.

[581] L Bibbs,et al. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. , 1994, Science.

[582] K. Arai,et al. Molecular cloning of a novel human cDNA encoding a zinc finger protein that binds to the interleukin-3 promoter , 1994, Molecular and Cellular Biology.

[583] J. Cleveland,et al. v-raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells. , 1994, Oncogene.

[584] R. J. Clem,et al. Control of programmed cell death by the baculovirus genes p35 and iap , 1994, Molecular and cellular biology.

[585] G. Hannon,et al. p21-containing cyclin kinases exist in both active and inactive states. , 1994, Genes & development.

[586] H. Sorimachi,et al. Calpain: new perspectives in molecular diversity and physiological‐pathological involvement , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[587] J. Mankovich,et al. Crystal structure of the cysteine protease interleukin-1β-converting enzyme: A (p20/p10)2 homodimer , 1994, Cell.

[588] Mark A. Murcko,et al. Structure and mechanism of interleukin-lβ converting enzyme , 1994, Nature.

[589] Tony Hunter,et al. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 , 1994, Cell.

[590] N. Sato,et al. JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region , 1994, Molecular and cellular biology.

[591] N. Russell,et al. Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells. , 1994, Experimental hematology.

[592] J. McCubrey,et al. Phorbol esters support the proliferation of a hematopoietic cell line by upregulating c-jun expression. , 1994, Oncogene.

[593] G. Hannon,et al. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA , 1994, Nature.

[594] D. Huhn,et al. Overexpression of the Raf-1 proto-oncogene in human myeloid leukemia. , 1994, Leukemia research.

[595] H. Hirsch,et al. Cyclosporin A inhibits growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNA , 1994, Nature.

[596] M. Vadas,et al. A mutation of the common receptor subunit for interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor, and IL-5 that leads to ligand independence and tumorigenicity. , 1994, Blood.

[597] S. Cameron,et al. Identification of a critical regulatory site in the human interleukin-3 promoter by in vivo footprinting. , 1994, Blood.

[598] A. Veerman,et al. Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[599] S. Winawer,et al. Two different signal transduction pathways can be activated by transforming growth factor beta 1 in epithelial cells. , 1994, The Journal of biological chemistry.

[600] A. Malkinson,et al. Calpain activation in apoptosis , 1994, Journal of cellular physiology.

[601] G. Dranoff,et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. , 1994, Science.

[602] T. Dexter,et al. Biological consequences of p160v-abl protein tyrosine kinase activity in a primitive, multipotent haemopoietic cell line. , 1994, Leukemia.

[603] E. White,et al. Bcl-2 blocks p53-dependent apoptosis , 1994, Molecular and cellular biology.

[604] P. Greenberg,et al. Mutations in the ras proto-oncogenes in patients with myelodysplastic syndromes. , 1994, Leukemia.

[605] Stephen J. Elledge,et al. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest , 1994, Cell.

[606] M. F. Shannon,et al. Two contiguous residues in human interleukin-3, Asp21 and Glu22, selectively interact with the alpha- and beta-chains of its receptor and participate in function. , 1994, The Journal of biological chemistry.

[607] J. Avruch,et al. Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O-tetradecanoylphorbol-13-acetate requires Raf and is necessary for transformation. , 1994, The Journal of biological chemistry.

[608] A. Brunet,et al. Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. , 1994, Oncogene.

[609] J. McCubrey,et al. Differential-effects of tumor promoters and cytokines on protooncogene expression in a hematopoietic cytokine-dependent cell-line. , 1994, Oncology reports.

[610] E. Wagner,et al. Down‐regulation of wild‐type p53 activity interferes with apoptosis of IL‐3‐dependent hematopoietic cells following IL‐3 withdrawal. , 1994, The EMBO journal.

[611] J. R. Smith,et al. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. , 1994, Experimental cell research.

[612] E. Harlow,et al. Identification of G1 kinase activity for cdk6, a novel cyclin D partner , 1994, Molecular and cellular biology.

[613] U. Rapp,et al. The complete sequence and promoter activity of the human A-raf-1 gene (ARAF1). , 1994, Genomics.

[614] M. Gossen,et al. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. , 1994, Molecular and cellular biology.

[615] D. Hossfeld,et al. Absence of point mutations in a functionally important part of the extracellular domain of the c-kit proto-oncogene in a series of patients with acute myeloid leukemia (AML). , 1994, Leukemia.

[616] A. Sanfridson,et al. Enhanced stability of interleukin-2 mRNA in MLA 144 cells. Possible role of cytoplasmic AU-rich sequence-binding proteins. , 1994, The Journal of biological chemistry.

[617] M. Fishman,et al. Prevention of vertebrate neuronal death by the crmA gene. , 1994, Science.

[618] S. Belinsky,et al. Analysis of K-ras, p53 and c-raf-1 mutations in beryllium-induced rat lung tumors. , 1994, Carcinogenesis.

[619] A. Wittinghofer,et al. Activation of Ras in vitro and in intact fibroblasts by the Vav guanine nucleotide exchange protein , 1994, Molecular and cellular biology.

[620] 鳥越俊彦. Interleukin-3 regulates the activity of the LYN protein-tyrosine kinase in myeloid-committed leukemic cell lines , 1994 .

[621] Sedlacek Hh. Vaccination for treatment of tumors: a critical comment. , 1994 .

[622] G. Hannon,et al. p21 is a component of active cell cycle kinases. , 1994, Cold Spring Harbor symposia on quantitative biology.

[623] K. Kishi,et al. Transfection of the bcr/abl oncogene into factor‐dependent cells by electroporation: acquisition of autonomous proliferation , 1994, Hematological oncology.

[624] G. Peters. Cell cycle. Stifled by inhibitions. , 1994, Nature.

[625] R. Salgia,et al. Factor independence of human myeloid leukemia cell lines is associated with increased phosphorylation of the proto-oncogene Raf-1. , 1994, Experimental hematology.

[626] H. Sedlacek. Vaccination for treatment of tumors: a critical comment. , 1994, Critical reviews in oncogenesis.

[627] M. Roussel,et al. D-type cyclins and their cyclin-dependent kinases: G1 phase integrators of the mitogenic response. , 1994, Cold Spring Harbor symposia on quantitative biology.

[628] J. McCubrey,et al. Differential regulation of glucose-transporter expression in hematopoietic-cells by oncogenic transformation and cytokine stimulation. , 1994, Oncology reports.

[629] L. Rohrschneider,et al. The effect of activating mutations on dimerization, tyrosine phosphorylation and internalization of the macrophage colony stimulating factor receptor. , 1994, Molecular biology of the cell.

[630] J. Massagué,et al. Cyclins, Cdks, and cyclin kinase inhibitors. , 1994, Cold Spring Harbor symposia on quantitative biology.

[631] R. Weinberg,et al. The cancer cell and the cell cycle clock. , 1994, Cold Spring Harbor symposia on quantitative biology.

[632] J. Dick,et al. Expression of bcr-abl abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism. , 1994, Blood.

[633] C. Turck,et al. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit , 1993, Nature.

[634] David Beach,et al. p21 is a universal inhibitor of cyclin kinases , 1993, Nature.

[635] J. Ihle,et al. Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor beta chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis , 1993, Molecular and cellular biology.

[636] W Zhang,et al. Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1 , 1993, Molecular and cellular biology.

[637] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[638] S. Elledge,et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[639] J. Bischoff,et al. Bcl-2 associates with the ras-related protein R-rasp23 , 1993, Nature.

[640] D. Williams,et al. Combination protocols of cytokine therapy with interleukin-3 and granulocyte-macrophage colony-stimulating factor in a primate model of radiation-induced marrow aplasia. , 1993, Blood.

[641] A. Ganser,et al. Restoration of impaired cytokine secretion from monocytes of patients with myelodysplastic syndromes after in vivo treatment with GM-CSF or IL-3. , 1993, Leukemia.

[642] J. McCubrey,et al. Retroviral infection can abrogate the factor-dependency of hematopoietic cells by autocrine and non-autocrine mechanisms depending on the presence of a functional viral oncogene. , 1993, Oncogene.

[643] R. Weinberg,et al. Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[644] M. Karin,et al. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. , 1993, Genes & development.

[645] K. Arai,et al. Signal transduction by the high‐affinity GM‐CSF receptor: two distinct cytoplasmic regions of the common beta subunit responsible for different signaling. , 1993, The EMBO journal.

[646] S. Emerson,et al. Molecular regulation of the human IL-3 gene: inducible T cell- restricted expression requires intact AP-1 and Elf-1 nuclear protein binding sites , 1993, The Journal of experimental medicine.

[647] D. Morrison,et al. Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase , 1993, Molecular and cellular biology.

[648] D. Adams,et al. Protease inhibitors selectively block T cell receptor-triggered programmed cell death in a murine T cell hybridoma and activated peripheral T cells , 1993, The Journal of experimental medicine.

[649] J. H. Park,et al. Overexpression of mitogen-activated protein kinase (ERK1) enhances T-cell cytokine gene expression: role of AP1, NF-AT, and NF-KB. , 1993, Blood.

[650] A. Miyajima,et al. Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5 , 1993 .

[651] M. McMahon,et al. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase , 1993, Molecular and cellular biology.

[652] M. Ewen,et al. TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest , 1993, Cell.

[653] J. Cleveland,et al. Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[654] G. Burgess,et al. Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells. , 1993, Blood.

[655] S. Aaronson,et al. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts. , 1993, Oncogene.

[656] D. Beach,et al. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. , 1993, Molecular biology of the cell.

[657] S. Korsmeyer,et al. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.

[658] C. Thompson,et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.

[659] S. Shurtleff,et al. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. , 1993, Genes & development.

[660] D. Beach,et al. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. , 1993, Genes & development.

[661] P. Warne,et al. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro , 1993, Nature.

[662] S. Elledge,et al. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1 , 1993, Nature.

[663] Jonathan A. Cooper,et al. Mammalian Ras interacts directly with the serine/threonine kinase raf , 1993, Cell.

[664] J. Hickman,et al. bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. , 1993, Cancer research.

[665] Walter Kolch,et al. Protein kinase Cα activates RAF-1 by direct phosphorylation , 1993, Nature.

[666] M. Vadas,et al. A cytokine receptor gene cluster in the X-Y pseudoautosomal region? , 1993, Blood.

[667] Charles J. Sherr,et al. Mammalian G1 cyclins , 1993, Cell.

[668] T. McKearn,et al. Radioimmunodetection of solid tumors. Future horizons and applications for radioimmunotherapy , 1993, Cancer.

[669] J. Blenis,et al. Failure of rapamycin to block proliferation once resting cells have entered the cell cycle despite inactivation of p70 S6 kinase. , 1993, The Journal of biological chemistry.

[670] K. Siminovitch,et al. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene , 1993, Nature Genetics.

[671] T. Roberts,et al. The cytoplasmic raf oncogene induces a neuronal phenotype in PC12 cells: a potential role for cellular raf kinases in neuronal growth factor signal transduction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[672] A. Altman,et al. Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation. , 1993, Science.

[673] J. McCubrey,et al. Autocrine transformation of hemopoietic cells resulting from cytokine message stabilization after intracisternal A particle transposition. , 1993, Oncogene.

[674] M. Pagano,et al. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. , 1993, Genes & development.

[675] U. Rapp,et al. A dominant negative Raf-1 mutant prevents v-Src-induced transformation. , 1993, Biochemical and biophysical research communications.

[676] J. Malter,et al. Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences. , 1993, The Journal of biological chemistry.

[677] R. Treisman,et al. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain , 1993, Cell.

[678] U. Rapp,et al. Oncogene activation: c-raf-1 gene mutations in experimental and naturally occurring tumors. , 1993, Toxicology letters.

[679] G. Mufti,et al. Myelodysplastic syndromes: from morphology to molecular biology. Part II. The molecular genetics of myelodysplasia. , 1993, International journal of hematology.

[680] D. Birnbaum,et al. Biochemical characterization and analysis of the transforming potential of the FLT3/FLK2 receptor tyrosine kinase. , 1993, Oncogene.

[681] K. Arai,et al. c‐fps/fes protein‐tyrosine kinase is implicated in a signaling pathway triggered by granulocyte‐macrophage colony‐stimulating factor and interleukin‐3. , 1993, The EMBO journal.

[682] J. Cidlowski,et al. Apoptosis: the biochemistry and molecular biology of programmed cell death. , 1993, Endocrine reviews.

[683] C. Stocking,et al. Induction of monocytic differentiation and tumorigenicity by v-Ha-ras in differentiation arrested hematopoietic cells. , 1993, Blood.

[684] James M. Roberts,et al. Cyclin-dependent regulation of G1 in mammalian fibroblasts. , 1993, Science.

[685] K. Kaushansky,et al. Transcriptional regulation of interleukin 3 (IL3) in primary human T lymphocytes. Role of AP-1- and octamer-binding proteins in control of IL3 gene expression. , 1993, The Journal of biological chemistry.

[686] M. F. Shannon,et al. The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[687] J. Fagerberg,et al. Effect of monoclonal antibody 17‐1A and gm‐CSF in patients with advanced colorectal carcinoma—long‐lasting, complete remissions can be induced , 1993, International journal of cancer.

[688] B. Mathey-Prevot,et al. Interleukin-3 expression by activated T cells involves an inducible, T-cell-specific factor and an octamer binding protein. , 1993, Blood.

[689] L. Schwartz,et al. Do all programmed cell deaths occur via apoptosis? , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[690] John Calvin Reed,et al. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. , 1993, Blood.

[691] M. Ewen,et al. TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest. , 1993, Cell.

[692] C. H. Janson. Biology of monoclonal antibodies in tumor therapy , 1993, Medical oncology and tumor pharmacotherapy.

[693] K. Arai,et al. Cytokine receptors and signal transduction. , 2005, Annual review of immunology.

[694] S. Asano,et al. Acquisition of interleukin-3 independence in FDC-P2 cells after transfection with the activated c-H-ras gene using a bovine papillomavirus-based plasmid vector. , 1992, Blood.

[695] M. F. Shannon,et al. A human interleukin 3 analog with increased biological and binding activities. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[696] M. Jung,et al. Mutations in the p53 gene in radiation-sensitive and -resistant human squamous carcinoma cells. , 1992, Cancer research.

[697] R. Strange,et al. Apoptosis in the genesis and prevention of cancer. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[698] J. Nevins,et al. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. , 1992, Science.

[699] T. Pawson,et al. A retrovirus encoding the v-fps protein-tyrosine kinase induces factor-independent growth and tumorigenicity in FDC-P1 cells. , 1992, Biochimica et biophysica acta.

[700] P. Bédard,et al. Regulation of gene expression in oncogenically transformed cells. , 1992, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[701] C. Y. Wang,et al. A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells , 1992, Journal of virology.

[702] M. Vekemans,et al. Clonal evolution in a myeloid cell line transformed to interleukin-3 independent growth by retroviral transduction and expression of p210bcr/abl. , 1992, Blood.

[703] R. Weinberg,et al. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins , 1992, Cell.

[704] R. Stephens,et al. 95-kilodalton B-Raf serine/threonine kinase: identification of the protein and its major autophosphorylation site , 1992, Molecular and cellular biology.

[705] M. Chan,et al. Genetic lesion in the carcinogenesis of cervical cancer. , 1992, Anticancer research.

[706] J. Avruch,et al. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. , 1992, Science.

[707] T. Pawson,et al. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction , 1992, Cell.

[708] A. Foti,et al. Molecular mechanisms in the evolution of chronic myelocytic leukemia. , 1992, Leukemia & lymphoma.

[709] G. Crabtree,et al. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation , 1992, Nature.

[710] M. Hallek,et al. Granulocyte-macrophage colony-stimulating factor, interleukin-3, and steel factor induce rapid tyrosine phosphorylation of p42 and p44 MAP kinase. , 1992, Blood.

[711] R. Black,et al. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme , 1992, Cell.

[712] A. Miyajima,et al. Two distinct functional high affinity receptors for mouse interleukin‐3 (IL‐3). , 1992, The EMBO journal.

[713] V. Fadok,et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. , 1992, Journal of immunology.

[714] T. Lints,et al. The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization. , 1992, Oncogene.

[715] U. Rapp,et al. Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase. , 1992, Genes & development.

[716] J. Maller,et al. Role for cyclin A in the dependence of mitosis on: Nature 354, 314–317 , 1992 .

[717] R. Pepperkok,et al. Cyclin A is required at two points in the human cell cycle. , 1992, The EMBO journal.

[718] V. Duronio,et al. p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[719] U. Zabel,et al. Purified I kappa B-beta is inactivated upon dephosphorylation. , 1992, The Journal of biological chemistry.

[720] N. Sigal,et al. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. , 1992, Annual review of immunology.

[721] W. Bursch,et al. Cell death by apoptosis and its protective role against disease. , 1992, Trends in pharmacological sciences.

[722] D. Morrison,et al. The role of Raf-1 phosphorylation in signal transduction. , 1992, Advances in cancer research.

[723] Y. Yamaguchi-Iwai,et al. Activation of lymphokine genes in T cells: role of cis-acting DNA elements that respond to T cell activation signals. , 1992, Pharmacology & therapeutics.

[724] U. Strausfeld,et al. Cyclin a is required for the onset of DNA replication in mammalian fibroblasts , 1991, Cell.

[725] J. McCubrey,et al. Differential effect of phorbol esters and interleukin-3 on protein kinase C isoform content and kinase activity in the FDC-P1 cell line. , 1991, Blood.

[726] J. Cleveland,et al. Identification of novel protein tyrosine phosphatases of hematopoietic cells by polymerase chain reaction amplification. , 1991, Blood.

[727] T. Hunter,et al. Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport , 1991, The Journal of cell biology.

[728] K. Arai,et al. Expression cloning of the human IL-3 receptor cDNA reveals a shared β subunit for the human IL-3 and GM-CSF receptors , 1991, Cell.

[729] M. Benito,et al. Differentiation of 3T3-L1 fibroblasts to adipocytes induced by transfection of ras oncogenes. , 1991, Science.

[730] R. T. Jones,et al. Human bronchial epithelial cells transformed by the c-raf-1 and c-myc protooncogenes induce multidifferentiated carcinomas in nude mice: a model for lung carcinogenesis. , 1991, Cancer research.

[731] G. Demartino,et al. Calcium-activated neutral protease (calpain) system: structure, function, and regulation. , 1991, Physiological reviews.

[732] K. Arai,et al. Reconstitution of functional receptors for human granulocyte/macrophage colony-stimulating factor (GM-CSF): evidence that the protein encoded by the AIC2B cDNA is a subunit of the murine GM-CSF receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[733] C. Thompson,et al. An inducible cytoplasmic factor (AU-B) binds selectively to AUUUA multimers in the 3' untranslated region of lymphokine mRNA , 1991, Molecular and cellular biology.

[734] A. Miyajima,et al. IL-1 up-regulates the expression of cytokine receptors on a factor-dependent human hemopoietic cell line, TF-1. , 1991, International immunology.

[735] L. Park,et al. Hematopoietic effects of a granulocyte‐macrophage colony‐stimulating factor/interleukin‐3 fusion protein , 1991, Cancer.

[736] G. Brewer,et al. An A + U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro , 1991, Molecular and cellular biology.

[737] I. Kramer,et al. TGF‐beta 1 induces phosphorylation of the cyclic AMP responsive element binding protein in ML‐CCl64 cells. , 1991, The EMBO journal.

[738] K. Arai,et al. Definition of a GC-rich motif as regulatory sequence of the human IL-3 gene: coordinate regulation of the IL-3 gene by CLE2/GC box of the GM-CSF gene in T cell activation. , 1991, International immunology.

[739] J. Malter,et al. The adenosine-uridine binding factor recognizes the AU-rich elements of cytokine, lymphokine, and oncogene mRNAs. , 1991, The Journal of biological chemistry.

[740] Marshall W. Anderson,et al. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice. , 1991, Cancer research.

[741] R. Pero,et al. Activated protooncogenes in human lung tumors from smokers. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[742] N. Heisterkamp,et al. Expression of the chronic myelogenous leukemia-associated p210bcr/abl oncoprotein in a murine IL-3 dependent myeloid cell line. , 1991, Oncogene.

[743] W. Kolch,et al. Raf-1 protein kinase is required for growth of induced NIH/3T3 cells , 1991, Nature.

[744] C. Marshall. Tumor suppressor genes , 1991, Cell.

[745] J. McCubrey,et al. Interleukin-3 and phorbol esters induce different patterns of immediate-early gene expression in an interleukin-3 dependent cell line. , 1991, Oncogene research.

[746] A. Wyllie,et al. Apoptosis: mechanisms and roles in pathology. , 1991, International review of experimental pathology.

[747] J. McCubrey,et al. Growth-promoting effects of insulin-like growth factor-1 (IGF-1) on hematopoietic cells: overexpression of introduced IGF-1 receptor abrogates interleukin-3 dependency of murine factor-dependent cells by a ligand-dependent mechanism. , 1991, Blood.

[748] R. Schreiber,et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death , 1990, Nature.

[749] I. Clark-lewis,et al. Interleukin-3 and granulocyte-macrophage colony-stimulating factor mediate rapid phosphorylation and activation of cytosolic c-raf. , 1990, The Journal of biological chemistry.

[750] R. Ross,et al. TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. , 1990, Cell.

[751] T. Shows,et al. tyk2, prototype of a novel class of non-receptor tyrosine kinase genes. , 1990, Oncogene.

[752] Tony Hunter,et al. Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B , 1990, Nature.

[753] S. Cannistra,et al. Signal transduction of the human granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors involves tyrosine phosphorylation of a common set of cytoplasmic proteins. , 1990, Blood.

[754] J. Bishop,et al. Transformation of early erythroid precursor cells (BFU-E) by a recombinant murine retrovirus containing v-erb-B. , 1990, Oncogene.

[755] C. Willman,et al. Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia [see comments] , 1990 .

[756] C. Willman,et al. Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia. , 1990, Blood.

[757] J. Massagué,et al. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation , 1990, Cell.

[758] G. Mufti,et al. Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemia. , 1990, Leukemia.

[759] N. Andrews,et al. Positive and negative elements regulate human interleukin 3 expression. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[760] K. Arai,et al. Cloning and expression of a gene encoding an interleukin 3 receptor-like protein: identification of another member of the cytokine receptor gene family. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[761] J. McCubrey,et al. Effects of phorbol esters on an interleukin-3-dependent cell line. , 1990, Blood.

[762] T. Pawson,et al. Mutational activation of c-raf-1 and definition of the minimal transforming sequence , 1990, Molecular and cellular biology.

[763] S. Korsmeyer,et al. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. , 1990, Journal of immunology.

[764] P. Nurse. Universal control mechanism regulating onset of M-phase , 1990, Nature.

[765] Anderson Sm,et al. Abrogation of IL-3 dependent growth requires a functional v-src gene product: evidence for an autocrine growth cycle. , 1990 .

[766] M. Worwood,et al. FMS mutations in myelodysplastic, leukemic, and normal subjects. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[767] U. Rapp,et al. raf oncogenes in carcinogenesis. , 1990, Critical reviews in oncogenesis.

[768] M. Carroll,et al. Role of raf-1 protein kinase in IL-3 and GM-CSF-mediated signal transduction. , 1990, Current topics in microbiology and immunology.

[769] T. Yokota,et al. Cytokines: coordinators of immune and inflammatory responses. , 1990, Annual review of biochemistry.

[770] J. McCubrey,et al. Structure and expression of the T cell receptor gamma locus in pre‐B and early hemopoietic cells , 1989, European journal of immunology.

[771] C. Thompson,et al. Regulation of interleukin 3 gene induction in normal human T cells. , 1989, The Journal of clinical investigation.

[772] A. Ridley,et al. Transforming growth factors-beta 1 and beta 2 are mitogens for rat Schwann cells , 1989, The Journal of cell biology.

[773] L. Rohrschneider,et al. Induction of macrophage colony-stimulating factor-dependent growth and differentiation after introduction of the murine c-fms gene into FDC-P1 cells , 1989, Molecular and cellular biology.

[774] K. Miyazono,et al. Establishment and characterization of a unique human cell line that proliferates dependently on GM‐CSF, IL‐3, or erythropoietin , 1989, Journal of cellular physiology.

[775] R. Kozłowski,et al. Heterogenous mechanisms of autocrine growth of AML blasts , 1989, British journal of haematology.

[776] T. Meeker,et al. The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene. , 1989, Blood.

[777] R. Lang,et al. Nonneoplastic hematopoietic myeloproliferative syndrome induced by dysregulated multi-CSF (IL-3) expression. , 1989, Blood.

[778] R. Black,et al. A pre-aspartate-specific protease from human leukocytes that cleaves pro-interleukin-1 beta. , 1989, The Journal of biological chemistry.

[779] J. Minna,et al. Loss of heterozygosity at the c-raf locus in small cell lung carcinoma. , 1989, Oncogene.

[780] A. Wilks. Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[781] J. McCubrey,et al. Abrogation of factor-dependence in two IL-3-dependent cell lines can occur by two distinct mechanisms. , 1989, Oncogene research.

[782] J. Downing,et al. A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential , 1988, Cell.

[783] G. Daley,et al. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[784] H. Drexler,et al. Evidence for pluripotent stem cell origin of idiopathic myelofibrosis: clonal analysis of a case characterized by a N-ras gene mutation. , 1988, Leukemia.

[785] David L. Vaux,et al. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.

[786] G. Klein,et al. Ratc-raf oncogene is located on chromosome 4 and may be activated by sequences from chromosome 13 , 1988, Somatic cell and molecular genetics.

[787] G. Cattoretti,et al. Selective growth response to IL‐3 of a human leukaemic cell line with megakaryoblastic features , 1988, British journal of haematology.

[788] Y. Ueyama,et al. B-raf, a new member of the raf family, is activated by DNA rearrangement , 1988, Molecular and cellular biology.

[789] J. Wang,et al. Hematopoietic growth factors activate the tyrosine phosphorylation of distinct sets of proteins in interleukin-3-dependent murine cell lines , 1988, Molecular and cellular biology.

[790] H. Ruley,et al. Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[791] J. Schlessinger,et al. Signal transduction through the EGF receptor transfected in IL-3-dependent hematopoietic cells. , 1988, Science.

[792] W. Jy,et al. Reversible dependence on growth factor interleukin-3 in myeloid cells expressing temperature sensitive v-abl oncogene. , 1988 .

[793] K. Miyamoto,et al. A B‐CELL LINE HAVING CHROMOSOME 14 ABERRATION AT BREAK BAND qll DERIVED FROM AN ADULT T‐CELL LEUKEMIA PATIENT , 1988, Japanese journal of cancer research : Gann.

[794] I. Hariharan,et al. bcr-abl oncogene renders myeloid cell line factor independent: potential autocrine mechanism in chronic myeloid leukemia. , 1988, Oncogene research.

[795] J. Wang,et al. Reversible dependence on growth factor interleukin-3 in myeloid cells expressing temperature sensitive v-abl oncogene. , 1988, Oncogene research.

[796] K. Miyamoto,et al. Specific abnormalities of chromosome 14 in patients with acute type of adult T‐cell leukemia/lymphoma , 1987, International journal of cancer.

[797] J. Watson,et al. Nature and specificity of lymphokine independence induced by a selectable retroviral vector expressing v-src , 1987, Molecular and cellular biology.

[798] E. Vellenga,et al. Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors. , 1987, Blood.

[799] T. Yamamoto,et al. Molecular cloning and characterization of an activated human c-raf-1 gene. , 1987, Molecular and cellular biology.

[800] J. Ihle,et al. The v-fms oncogene induces factor-independent growth and transformation of the interleukin-3-dependent myeloid cell line FDC-P1. , 1987, Molecular and cellular biology.

[801] T. Sugimura,et al. Rat c-raf oncogene activation by a rearrangement that produces a fused protein , 1987, Molecular and Cellular Biology.

[802] E. Reddy,et al. Effect of Abelson murine leukemia virus on granulocytic differentiation and interleukin-3 dependence of a murine progenitor cell line. , 1987, Oncogene.

[803] E. Canalis,et al. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. , 1987, The Journal of biological chemistry.

[804] S. Latt,et al. Mapping by chromosome sorting of several gene probes, including c-myc, to the derivative chromosomes of a 3;8 translocation associated with familial renal cancer. , 1986, Cytometry.

[805] D. Baltimore,et al. Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line , 1986, Molecular and cellular biology.

[806] J. Griffin,et al. Autocrine secretion of GM-CSF in acute myeloblastic leukemia. , 1986, Blood.

[807] C. Begley,et al. Effects of purified bacterially synthesized murine multi-CSF (IL-3) on hematopoiesis in normal adult mice. , 1986, Blood.

[808] H. Moses,et al. Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[809] B. Franza,et al. In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes , 1986, Cell.

[810] J. Sklar,et al. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[811] J. McCubrey,et al. Enrichment of hematopoietic precursor cells and cloning of multipotential B-lymphocyte precursors. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[812] D. Bar-Sagi,et al. Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation , 1985, Cell.

[813] M. Steinmetz,et al. IL3-dependent mouse clones that express B-220 surface antigen, contain ig genes in germ-line configuration, and generate B lymphocytes in vivo , 1985, Cell.

[814] J. Pumphrey,et al. Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism , 1985, Cell.

[815] A. Burgess,et al. Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism , 1985, Cell.

[816] S. Korsmeyer,et al. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around Jh on chromosome 14 and near a transcriptional unit on 18 , 1985, Cell.

[817] J. Ihle,et al. Evidence for specific receptors for interleukin 3 on lymphokine-dependent cell lines established from long-term bone marrow cultures. , 1984, Journal of immunology.

[818] A. Wyllie,et al. Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis , 1984, The Journal of pathology.

[819] J. Cohen,et al. Endogenous endonuclease-induced DNA fragmentation: an early event in cell-mediated cytolysis. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[820] J. Ihle,et al. Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity. , 1983, Journal of immunology.

[821] J. Greenberger,et al. Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[822] T. Dexter,et al. Characterization and partial purification of a haemopoietic cell growth factor in WEHI-3 cell conditioned medium. , 1983, The Biochemical journal.

[823] J. Schrader,et al. A T cell-derived factor stimulating multipotential hemopoietic stem cells: molecular weight and distinction from T cell growth factor and T cell-derived granulocyte-macrophage colony-stimulating factor. , 1982, Journal of immunology.

[824] J. Ihle,et al. Regulation of T cell differentiation: in vitro induction of 20 alpha-hydroxysteroid dehydrogenase in splenic lymphocytes from athymic mice by a unique lymphokine. , 1981, Journal of immunology.

[825] H. Dvorak,et al. Inducer T lymphocytes synthesize a factor that stimulates proliferation of cloned mast cells , 1981, Nature.

[826] P. Kamoun,et al. Histamine production during the anti-allograft response. Demonstration of a new lymphokine enhancing histamine synthesis , 1981, The Journal of experimental medicine.

[827] J. Culvenor,et al. The persisting (P) cell: histamine content, regulation by a T cell-derived factor, origin from a bone marrow precursor, and relationship to mast cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[828] E. Scolnick,et al. Growth of factor-dependent hemopoietic precursor cell lines , 1980, The Journal of experimental medicine.

[829] A. Wyllie. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation , 1980, Nature.

[830] A. Wyllie,et al. Cell death: the significance of apoptosis. , 1980, International review of cytology.

[831] A. Pardee,et al. A restriction point for control of normal animal cell proliferation. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[832] A. Wyllie,et al. Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.